Phenominer Database Results (1295 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
SD blood sodium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 71 days-85 days 6 150.33 mmol/l 0.76 1.86 automated blood analysis 0.0 0 Siemens biochemical analyzer 85128 1602
SD blood calcium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 85 days-99 days 6 10.08 mg/dl 0.1 0.25 automated blood analysis 0.0 0 Siemens biochemical analyzer 85154 1602
SD blood total cholesterol level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 71 days-85 days 6 86.8 mg/dl 5.76 14.12 automated blood analysis 0.0 0 Siemens biochemical analyzer 85170 1602
SD liver wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 85 days-99 days 6 3.69 g 0.16 0.38 post excision weight measurement 0.0 0 85204 1602
SD both kidneys wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 85 days-99 days 6 0.76 g 0.04 0.1 post excision weight measurement 0.0 0 85210 1602
SD spleen wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 71 days-85 days 6 0.2 g 0.0 0.01 post excision weight measurement 0.0 0 85244 1602
SD spleen wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 85 days-99 days 6 0.23 g 0.0 0.01 post excision weight measurement 0.0 0 85253 1602
SD brain wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 71 days-85 days 6 0.72 g 0.05 0.13 post excision weight measurement 0.0 0 85255 1602
SD brain wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 71 days-85 days 6 0.74 g 0.03 0.07 post excision weight measurement 0.0 0 85256 1602
SD brain wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 85 days-99 days 6 1.09 g 0.01 0.03 post excision weight measurement 0.0 0 85264 1602
SD adrenal gland wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 71 days-85 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85267 1602
SD adrenal gland wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 71 days-85 days 6 0.04 g 0.0 0.01 post excision weight measurement 0.0 0 85272 1602
SD uterus wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 71 days-85 days 6 0.35 g 0.06 0.15 post excision weight measurement 0.0 0 85284 1602
SD body weight acetaminophen (250 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 211.0 g body weighing method 0.0 0 84766 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 262.4 g body weighing method 0.0 0 84779 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 246.1 g body weighing method 0.0 0 84786 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 255.5 g body weighing method 0.0 0 84788 1602
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 208.8 g body weighing method 0.0 0 84790 1602
SD body weight acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 252.7 g body weighing method 0.0 0 84792 1602
SD body weight acetaminophen (250 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 161.2 g body weighing method 0.0 0 84801 1602
SD body weight acetaminophen (250 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 170.0 g body weighing method 0.0 0 84802 1602
SD body weight acetaminophen (500 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 134.7 g body weighing method 0.0 0 84804 1602
SD body weight acetaminophen (500 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 147.9 g body weighing method 0.0 0 84805 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 134.2 g body weighing method 0.0 0 84809 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 137.3 g body weighing method 0.0 0 84814 1602
SD body weight acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 153.9 g body weighing method 0.0 0 84821 1602
SD body weight acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 160.7 g body weighing method 0.0 0 84822 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 33.1 g/d unspecified method 0.0 0 84824 1602
SD food intake rate acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 31.7 g/d unspecified method 0.0 0 84835 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 34.9 g/d unspecified method 0.0 0 84836 1602
SD red blood cell count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 8.47 x 10E6 cells/ul 0.19 0.47 unspecified method 0.0 0 84896 1602
SD blood glucose level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 85 days-99 days 6 72.48 mg/dl 12.78 31.31 automated blood analysis 0.0 0 Siemens biochemical analyzer 84991 1602
SD blood urea nitrogen level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 85 days-99 days 6 21.0 mg/dl 0.63 1.55 automated blood analysis 0.0 0 Siemens biochemical analyzer 85046 1602
SD blood creatinine level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 71 days-85 days 6 0.4 mg/dl 0.0 0.0 automated blood analysis 0.0 0 Siemens biochemical analyzer 85066 1602
SD blood alanine aminotransferase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 71 days-85 days 6 59.8 U/l 2.44 5.98 automated blood analysis 0.0 0 Siemens biochemical analyzer 85085 1602
SD blood alanine aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 85 days-99 days 6 39.74 U/l 8.84 21.66 automated blood analysis 0.0 0 Siemens biochemical analyzer 85088 1602
SD blood alanine aminotransferase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 71 days-85 days 6 59.67 U/l 3.76 9.22 automated blood analysis 0.0 0 Siemens biochemical analyzer 85091 1602
SD blood bilirubin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 85 days-99 days 6 0.52 mg/dl 0.09 0.22 automated blood analysis 0.0 0 Siemens biochemical analyzer 85111 1602
SD blood potassium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 71 days-85 days 6 5.0 mmol/l 0.2 0.48 automated blood analysis 0.0 0 Siemens biochemical analyzer 85132 1602
SD blood phosphate level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 85 days-99 days 6 5.5 mg/dl 0.15 0.37 automated blood analysis 0.0 0 Siemens biochemical analyzer 85166 1602
SD blood calcium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 71 days-85 days 6 10.2 mg/dl 0.1 0.24 automated blood analysis 0.0 0 Siemens biochemical analyzer 85145 1602
SD blood calcium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 71 days-85 days 6 10.0 mg/dl 0.04 0.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85151 1602
SD blood triglyceride level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 85 days-99 days 6 58.81 mg/dl 10.11 24.76 automated blood analysis 0.0 0 Siemens biochemical analyzer 85184 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 34.5 g/d unspecified method 0.0 0 84841 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 33.7 g/d unspecified method 0.0 0 84842 1602
SD blood globulin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 71 days-85 days 6 3.0 g/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85026 1602
SD blood globulin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 85 days-99 days 6 3.08 g/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85034 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 139.0 g body weighing method 0.0 0 84819 1602
SD food intake rate acetaminophen (250 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 34.3 g/d unspecified method 0.0 0 84829 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 25.7 g/d unspecified method 0.0 0 84863 1602
SD red blood cell count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 8.93 x 10E6 cells/ul 0.23 0.56 unspecified method 0.0 0 84911 1602
SD hematocrit acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 44.38 % 0.79 1.94 unspecified method 0.0 0 84952 1602
SD hematocrit control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 41.03 % 1.15 2.81 unspecified method 0.0 0 84957 1602
SD testis wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 71 days-85 days 6 1.03 g 0.15 0.37 post excision weight measurement 0.0 0 85281 1602
SD uterus wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 71 days-85 days 6 0.28 g 0.03 0.07 post excision weight measurement 0.0 0 85285 1602
SD uterus wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 71 days-85 days 6 0.45 g 0.05 0.12 post excision weight measurement 0.0 0 85286 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 22.4 g/d unspecified method 0.0 0 84848 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 24.5 g/d unspecified method 0.0 0 84850 1602
SD both kidneys wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 71 days-85 days 6 0.85 g 0.04 0.09 post excision weight measurement 0.0 0 85213 1602
SD both kidneys wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 85 days-99 days 6 0.87 g 0.03 0.07 post excision weight measurement 0.0 0 85216 1602
SD both lungs wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 71 days-85 days 6 0.72 g 0.04 0.09 post excision weight measurement 0.0 0 85219 1602
SD both lungs wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 71 days-85 days 6 0.73 g 0.02 0.05 post excision weight measurement 0.0 0 85227 1602
SD both lungs wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 85 days-99 days 6 0.79 g 0.04 0.09 post excision weight measurement 0.0 0 85228 1602
SD blood hemoglobin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 85 days-99 days 6 11.02 g/dl 0.23 0.57 unspecified method 0.0 0 84949 1602
SD platelet count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 71 days-85 days 6 1095.83 x 1000 cells/ul 79.61 195.01 unspecified method 0.0 0 84975 1602
SD platelet count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 71 days-85 days 6 1263.0 x 1000 cells/ul 34.55 84.62 unspecified method 0.0 0 84978 1602
SD blood glucose level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 71 days-85 days 6 103.7 mg/dl 5.52 13.52 automated blood analysis 0.0 0 Siemens biochemical analyzer 84988 1602
SD blood albumin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 85 days-99 days 6 2.93 g/dl 0.55 1.35 automated blood analysis 0.0 0 Siemens biochemical analyzer 85003 1602
SD blood albumin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 3.5 g/dl 0.06 0.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85005 1602
SD blood albumin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 3.5 g/dl 0.14 0.35 automated blood analysis 0.0 0 Siemens biochemical analyzer 85006 1602
SD blood albumin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 4.6 g/dl 0.38 0.92 automated blood analysis 0.0 0 Siemens biochemical analyzer 85008 1602
SD plasma total protein level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 71 days-85 days 6 63.0 mg/ml 0.82 2.0 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85011 1602
SD liver wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 85 days-99 days 6 3.18 g 0.13 0.31 post excision weight measurement 0.0 0 85195 1602
SD blood glucose level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 71 days-85 days 6 115.3 mg/dl 5.86 14.35 automated blood analysis 0.0 0 Siemens biochemical analyzer 84987 1602
SD blood albumin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 3.3 g/dl 0.05 0.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 84999 1602
SD blood albumin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 3.2 g/dl 0.09 0.22 automated blood analysis 0.0 0 Siemens biochemical analyzer 85001 1602
SD heart rate artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 436.0 beats/min 18.0 44.09 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98793 2160
SD heart rate sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 365.0 beats/min 15.0 36.74 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98800 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 70.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98808 2160
SD body weight controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 12 290.6 g 6.8 23.56 body weighing method 0.0 unx 97 days 100635 2499
SD serum creatinine level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood creatinine amount female 0 days 13 1.65 mg/dl 0.14 0.5 serum creatinine analysis 0.0 unx 97 days 100637 2499
SD creatinine clearance controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. glomerular filtration trait female 0 days 12 0.56 ml/min 0.03 0.1 serum creatinine analysis 0.0 unx 97 days 100643 2499
SD serum parathyroid hormone level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood parathyroid hormone amount female 0 days 13 3496.0 pg/ml 862.0 3107.99 serum parathyroid hormone analysis 0.0 unx 97 days 100647 2499
SD serum parathyroid hormone level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood parathyroid hormone amount female 0 days 12 371.0 pg/ml 100.0 346.41 serum parathyroid hormone analysis 0.0 unx 97 days 100648 2499
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 5.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98820 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 8.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98828 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.2 null 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98868 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.8 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98876 2160
SD ejection fraction sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 64.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98885 2160
SD left kidney wet weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 5 1.49 g 0.1 0.23 post excision weight measurement 0.0 unx 13 days remnant kidney 101546 2602
SD systolic blood pressure sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 6 undefined 118.0 mmHg 3.67 9.0 tail cuff plethysmography 0.0 sham unx 13 days 101547 2602
SD systolic blood pressure unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 5 undefined 149.0 mmHg 9.39 21.0 tail cuff plethysmography 0.0 unx 13 days 101550 2602
SD body weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 300.0 g 10.96 31.0 body weighing method 0.0 unx 28 days 101608 2602
SD urine protein excretion rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. total urine protein amount male 90 days 9 5.0 mg/d 1.0 3.0 urine protein analysis 0.0 0 101234 2582
SD serum creatinine level left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. blood creatinine amount male 0 days 7 2.3 mg/dl 0.5 1.32 automated serum creatinine analysis 0.0 unx 70 days 98991 2179
SD serum creatinine level left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. blood creatinine amount male 0 days 7 0.8 mg/dl 0.1 0.26 automated serum creatinine analysis 0.0 unx 70 days 98993 2179
SD kidney sclerotic glomeruli count to total glomeruli count ratio sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 6 1.9 % 0.49 1.2 ex vivo light microscopy with histochemistry 0.0 sham unx 28 days 101603 2602
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.2 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98843 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.9 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98848 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98860 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98861 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.6 mm 0.1 0.24 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98865 2160
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 7985.0 mmHg/s 200.0 489.9 vascular transducer tipped catheter 1.0 sham ACF 2 days 98889 2160
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -5661.0 mmHg/s 312.0 764.24 vascular transducer tipped catheter 1.0 ACF 2 days 98892 2160
SD body weight left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 257.0 g 4.0 10.58 body weighing method 0.0 unx 0 98926 2179
SD body weight left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 9 308.0 g 10.0 30.0 body weighing method 0.0 unx 56 days 98933 2179
SD mean arterial blood pressure left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 9 148.0 mmHg 4.0 12.0 tail cuff plethysmography 0.0 unx 28 days 98942 2179
SD mean arterial blood pressure left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 9 129.0 mmHg 4.0 12.0 body weighing method 0.0 unx 70 days 98948 2179
SD urine total protein excretion rate left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 97.0 mg/d 4.0 10.58 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98958 2179
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 23 26.8 null 2.46 11.8 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98219 2040
SD urine protein level to urine creatinine level ratio left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 3.4 null 0.3 0.9 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98966 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 13.6 null 3.3 9.9 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98972 2179
SD body weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 563.0 g 12.37 35.0 body weighing method 0.0 stz 154 days 99891 2358
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 16 38.2 s 3.53 14.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 1 days time to platform 98241 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 16 14.9 s 1.78 7.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 3 days time to platform 98243 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 10 36.0 s 3.76 11.9 Morris water maze method 60.0 coronal plane rotational acceleration of the head 1 days time in platform 98244 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 65.1 s 12.59 35.6 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 30 days time in open arms 98257 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 17 64.9 s 10.67 44.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days time in open arms 98258 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 18.9 s 4.21 11.9 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 30 days time to platform 98263 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 11 38.5 s 3.95 13.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 29 days time to platform 98268 2040
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 4.6 null 0.3 0.67 echocardiography 0.0 sham ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99357 2278
SD systolic blood pressure nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. arterial blood pressure trait male 140 days 8 serial mean 134.3 mmHg 13.2 37.34 tail cuff plethysmography 0.0 unx 84 days 100116 2419
SD heart weight to body weight ratio sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 2.7 g/kg 0.1 0.28 post excision weight measurement 0.0 sham ACF 28 days 99199 2278
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 98 days 8 0.5 mg/g 0.1 0.28 post excision weight measurement 0.0 sham ACF 28 days 99207 2278
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 271.0 beats/min 11.0 31.11 vascular transducer tipped catheter 0.0 ACF 28 days 99216 2278
SD heart rate sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 175 days 10 217.0 beats/min 12.0 37.95 vascular transducer tipped catheter 0.0 sham ACF 105 days 99217 2278
SD heart rate artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 175 days 10 220.0 beats/min 5.0 15.81 vascular transducer tipped catheter 0.0 ACF 105 days 99218 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8947.0 mmHg/s 745.0 2107.18 vascular transducer tipped catheter 0.0 ACF 28 days 99228 2278
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 48.8 s 2.83 8.0 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 1 days time to platform 98228 2040
SD systolic blood pressure controlled enalapril content drinking water (5 mg/kg/d) (for 10 days) Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 130 days 1 mean of 3 samples - 1 per minute serial mean 117.0 mmHg 4.0 4.0 tail cuff plethysmography 0.0 0 100178 2439
SD creatinine clearance control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. glomerular filtration trait male 60 days 3 0.0 ml/min 0.0 0.0 urine creatinine analysis 0.0 0 100210 2439
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 17.8 s 3.75 10.6 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 2 days time to platform 98229 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 21.2 s 4.38 12.4 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 3 days time to platform 98230 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 21 34.5 s 2.44 11.2 Morris water maze method 60.0 coronal plane rotational acceleration of the head 1 days time to platform 98235 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 21 21.2 s 2.44 11.2 Morris water maze method 60.0 coronal plane rotational acceleration of the head 3 days time to platform 98237 2040
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 7.7 null 0.5 1.41 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99244 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 40.0 % 1.0 3.16 echocardiography 0.0 sham ACF 105 days 99257 2278
SD heart left ventricle interstitial norepinephrine level during a period of time sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 98 days 8 6.2 pg/hr 1.0 2.83 enzyme linked immunosorbent assay 0.0 sham ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99267 2278
SD heart left ventricle interstitial norepinephrine level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 175 days 10 10.2 pg/hr 1.0 3.16 enzyme linked immunosorbent assay 0.0 ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99270 2278
SD plasma norepinephrine level sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 98 days 8 93.0 pg/ml 12.0 33.94 enzyme linked immunosorbent assay 0.0 sham ACF 28 days pl bk 99283 2278
SD heart rate sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 359.0 beats/min 6.0 13.42 vascular transducer tipped catheter 0.0 sham ACF 2 days 99291 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 4.2 mmHg 0.0 0.0 vascular transducer tipped catheter 0.0 sham ACF 28 days 99311 2278
SD left ventricular end-systolic blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 85.0 mmHg 3.0 7.94 vascular transducer tipped catheter 0.0 sham ACF 28 days 99319 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 70.0 mmHg 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99322 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 8505.0 mmHg/s 450.0 1190.59 vascular transducer tipped catheter 0.0 sham ACF 28 days 99327 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8937.0 mmHg/s 423.0 1196.42 vascular transducer tipped catheter 0.0 ACF 28 days 99330 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -5948.0 mmHg/s 131.0 370.52 vascular transducer tipped catheter 0.0 ACF 28 days 99338 2278
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 7.6 mm 0.1 0.26 echocardiography 0.0 sham ACF 28 days 99345 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 5.8 null 0.2 0.45 echocardiography 0.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99356 2278
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77 days 6 3.09 g/kg 0.03 0.07 ex vivo method 0.0 lad occlusion 28 days 101083 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77 days 6 0.67 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101091 2564
SD heart left atrium weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77 days 6 0.07 mg/g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 28 days law/bw 101112 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77 days 6 0.11 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days raw/bw 101119 2564
SD heart right atrium weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77 days 6 0.1 mg/g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 28 days raw/bw 101120 2564
SD heart right atrium weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189 days 6 0.08 mg/g 0.01 0.01 ex vivo method 0.0 sham lad occlusion 140 days raw/bw 101122 2564
SD heart septum weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 189 days 6 0.29 g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 140 days septum 101126 2564
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 120 days 11 mean of 3 samples - 1 per minute serial mean 133.0 mmHg 1.81 6.0 tail cuff plethysmography 0.0 0 100172 2439
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 180 days 3 mean of 3 samples - 1 per minute serial mean 134.0 mmHg 2.31 4.0 tail cuff plethysmography 0.0 0 100174 2439
SD ejection fraction artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 8 63.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99376 2278
SD ejection fraction artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 8 71.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99378 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 54.0 g/cm2 3.0 6.71 echocardiography 0.0 ACF 2 days 99396 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 2.1 % 0.1 0.22 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 2 days 99404 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 8 3.2 % 0.1 0.28 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 28 days 99410 2278
SD body weight control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 738.0 g 27.93 79.0 body weighing method 0.0 0 99916 2358
SD systolic blood pressure streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 150.0 mmHg 1.41 4.0 tail cuff plethysmography 0.0 stz 224 days 99923 2358
SD glomerular filtration rate to body weight ratio streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.65 ml/min/100g 0.02 0.06 inulin analysis by thiourea-resorcinol assay 0.0 stz 224 days 99927 2358
SD effective renal plasma flow streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.31 ml/min/100g 0.08 0.22 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days 99929 2358
SD effective renal plasma flow control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.33 ml/min/100g 0.07 0.2 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 99931 2358
SD serum immunoglobulin E level control condition Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood immunoglobulin E amount not specified 0 days 8 0.1 ug/l 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 error not defined 105406 3015
SD retinal uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 180.0 % 12.0 20.78 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106116 3028
SD retinal uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 27.9 % 5.7 9.87 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106119 3028
SD retinal uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 439.0 % 57.0 98.73 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106122 3028
SD aqueous humor uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and quinidine (10 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 11.7 % 0.6 1.04 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106133 3028
SD aqueous humor uptake index of digoxin tritiated quinidine (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 17.5 % 5.8 10.05 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106135 3028
SD brain uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and quinidine (10 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 18.2 % 1.2 2.08 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106151 3028
SD verapamil equilibrated distribution volume in aqueous humor tritiated verapamil (10 uCi) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 0.07 ml/g 0.0 0.0 liquid scintillation counting 0.0 carotid injection 15 sec post excision 106109 3028
SD aqueous humor uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 9.48 % 0.55 0.95 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106137 3028
SD serum interleukin-9 level control condition Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-9 amount not specified 0 days 8 0.08 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105414 3015
SD nifedipine mean residence time nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. xenobiotic pharmacokinetics trait both 56 days 6 38.06 min 5.41 13.25 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling mrt nifidepine 105718 3020
SD body weight acetaminophen (250 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 182.3 g body weighing method 0.0 0 84765 1602
SD food intake rate acetaminophen (250 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 21.3 g/d unspecified method 0.0 0 84852 1602
SD food intake rate acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 26.0 g/d unspecified method 0.0 0 84855 1602
SD red blood cell count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 8.56 x 10E6 cells/ul 0.2 0.49 unspecified method 0.0 0 84895 1602
SD plasma total protein level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 71 days-85 days 6 65.0 mg/ml 0.49 1.2 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85017 1602
SD blood urea nitrogen level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 85 days-99 days 6 16.0 mg/dl 0.89 2.19 automated blood analysis 0.0 0 Siemens biochemical analyzer 85045 1602
SD blood albumin level to blood globulin level ratio acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 0.9 null 0.03 0.07 automated blood analysis 0.0 0 Siemens biochemical analyzer 85048 1602
SD blood creatinine level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 71 days-85 days 6 0.4 mg/dl 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85062 1602
SD blood aspartate aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 85 days-99 days 6 155.67 U/l 3.85 9.42 automated blood analysis 0.0 0 Siemens biochemical analyzer 85081 1602
SD both kidneys wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 85 days-99 days 6 0.84 g 0.02 0.05 post excision weight measurement 0.0 0 85211 1602
SD adrenal gland wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 71 days-85 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85268 1602
SD blood differential white blood cell count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 71 days-85 days 6 11.3 x 1000 cells/ul 1.47 3.6 unspecified method 0.0 0 84887 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 71 days-85 days 6 11.87 % 0.18 0.44 unspecified method 0.0 0 84966 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 85 days-99 days 6 11.35 % 0.16 0.38 unspecified method 0.0 0 84974 1602
SD blood glucose level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 71 days-85 days 6 86.8 mg/dl 4.51 11.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 84990 1602
SD liver weight as percentage of body weight 2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. liver mass female 84 days 10 5.07 % 0.23 0.72 post excision weight measurement 0.0 0 105725 3021
SD blood calcium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 71 days-85 days 6 10.0 mg/dl 0.09 0.23 automated blood analysis 0.0 0 Siemens biochemical analyzer 85144 1602
SD blood potassium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 71 days-85 days 6 4.57 mmol/l 0.08 0.19 automated blood analysis 0.0 0 Siemens biochemical analyzer 85137 1602
SD renal plasma flow to body weight ratio control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney plasma flow trait male 420 days-450 days 9 1.0 ml/min/100g 0.06 0.18 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 101231 2582
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.2 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 2 days 98790 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 72.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98814 2160
SD serum creatinine level control condition Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood creatinine amount female 0 days 8 0.58 mg/dl 0.03 0.08 serum creatinine analysis 0.0 0 days 100636 2499
SD serum creatinine level left nephrectomy (for 70 days) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. blood creatinine amount male 0 days 5 0.3 mg/dl 0.0 0.0 automated serum creatinine analysis 0.0 unx 70 days 103796 2179
SD adrenal gland weight sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 6 51.0 mg 1.63 4.0 post excision weight measurement 0.0 sham unx 13 days 101559 2602
SD plasma renin activity level sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. renin activity male 0 days 6 3.1 ng/ml/h 0.29 0.7 radioimmunoassay 0.0 sham unx 13 days 101563 2602
SD body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 315.0 g 9.55 27.0 body weighing method 0.0 unx 28 days 101607 2602
SD urine total protein excretion rate unilateral nephrectomy (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 8 201.0 mg/d 31.47 89.0 urine protein analysis 0.0 unx 14 days 101621 2602
SD adrenal gland weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 6 60.0 mg 3.27 8.0 post excision weight measurement 0.0 unx 28 days 101602 2602
SD red blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 8.26 x 10E6 cells/ul 0.24 0.59 unspecified method 0.0 0 84908 1602
SD body weight left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 301.0 g 5.0 13.23 body weighing method 0.0 unx 28 days 98929 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 14.4 null 2.2 5.82 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98971 2179
SD left kidney wet weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 1.9 g 0.04 0.1 post excision weight measurement 0.0 stz 154 days 99894 2358
SD systolic blood pressure control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 127.0 mmHg 1.06 3.0 tail cuff plethysmography 0.0 0 99901 2358
SD body weight acetaminophen (500 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 209.3 g body weighing method 0.0 0 84771 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 33.5 g/d unspecified method 0.0 0 84840 1602
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 5.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 sham ACF 360 min 98819 2160
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 2.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 sham ACF 720 min 98821 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 71.0 mmHg 5.0 12.25 vascular transducer tipped catheter 1.0 ACF 5 days 98836 2160
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 24.1 s 3.64 10.3 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 29 days time to platform 98262 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 11 13.0 s 1.54 5.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 30 days time to platform 98269 2040
SD left ventricle end-systolic wall stress sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 49.0 g/cm2 9.0 20.12 echocardiography 0.0 sham ACF 2 days 99397 2278
SD blood albumin level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood albumin amount male 140 days 7 3.1 g/dl 0.2 0.53 automated blood albumin analysis 0.0 unx 84 days 100166 2419
SD plasma bradykinin level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 175 days 10 29.0 pg/ml 5.0 15.81 radioimmunoassay 0.0 ACF 105 days 99282 2278
SD mean arterial blood pressure sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 106.0 mmHg 1.0 2.24 vascular transducer tipped catheter 0.0 sham ACF 2 days 99301 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 5.0 mmHg 1.0 2.24 vascular transducer tipped catheter 0.0 sham ACF 2 days 99309 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 -7422.0 mmHg/s 236.0 624.4 vascular transducer tipped catheter 0.0 sham ACF 28 days 99336 2278
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 7.0 mm 0.1 0.22 echocardiography 0.0 sham ACF 2 days 99341 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.6 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99344 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.0 mm 0.2 0.45 echocardiography 0.0 sham ACF 2 days 99347 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.1 mm 0.2 0.45 echocardiography 0.0 sham ACF 2 days 99349 2278
SD blood sodium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 71 days-85 days 6 143.8 mmol/l 0.6 1.47 automated blood analysis 0.0 0 Siemens biochemical analyzer 85119 1602
SD blood sodium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 85 days-99 days 6 123.26 mmol/l 24.32 59.56 automated blood analysis 0.0 0 Siemens biochemical analyzer 85123 1602
SD blood sodium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 71 days-85 days 6 146.5 mmol/l 0.43 1.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85125 1602
SD blood sodium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 71 days-85 days 6 146.67 mmol/l 0.62 1.51 automated blood analysis 0.0 0 Siemens biochemical analyzer 85126 1602
SD blood sodium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 85 days-99 days 6 145.33 mmol/l 0.92 2.25 automated blood analysis 0.0 0 Siemens biochemical analyzer 85130 1602
SD blood phosphate level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 85 days-99 days 6 4.06 mg/dl 0.91 2.22 automated blood analysis 0.0 0 Siemens biochemical analyzer 85160 1602
SD blood total cholesterol level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 85 days-99 days 6 60.1 mg/dl 12.24 29.99 automated blood analysis 0.0 0 Siemens biochemical analyzer 85172 1602
SD blood triglyceride level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 71 days-85 days 6 44.0 mg/dl 12.59 30.84 automated blood analysis 0.0 0 Siemens biochemical analyzer 85187 1602
SD liver wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 71 days-85 days 6 4.31 g 0.1 0.24 post excision weight measurement 0.0 0 85193 1602
SD liver wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 85 days-99 days 6 3.51 g 0.13 0.31 post excision weight measurement 0.0 0 85205 1602
SD both kidneys wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 71 days-85 days 6 0.88 g 0.02 0.06 post excision weight measurement 0.0 0 85207 1602
SD both kidneys wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 71 days-85 days 6 0.94 g 0.03 0.08 post excision weight measurement 0.0 0 85212 1602
SD heart wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass female 71 days-85 days 6 0.41 g 0.02 0.04 post excision weight measurement 0.0 0 85237 1602
SD spleen wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 85 days-99 days 6 0.21 g 0.01 0.02 post excision weight measurement 0.0 0 85247 1602
SD brain wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 85 days-99 days 6 0.68 g 0.01 0.03 post excision weight measurement 0.0 0 85259 1602
SD brain wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 71 days-85 days 6 1.03 g 0.04 0.11 post excision weight measurement 0.0 0 85261 1602
SD testis wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 85 days-99 days 6 1.0 g 0.03 0.08 post excision weight measurement 0.0 0 85282 1602
SD red blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 8.31 x 10E6 cells/ul 0.22 0.53 unspecified method 0.0 0 84894 1602
SD plasma total protein level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 85 days-99 days 6 66.0 mg/ml 0.57 1.4 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85021 1602
SD blood albumin level to blood globulin level ratio acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 1.1 null 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85055 1602
SD blood creatinine level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 71 days-85 days 6 0.4 mg/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85061 1602
SD blood creatinine level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 85 days-99 days 6 0.33 mg/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85069 1602
SD blood creatinine level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 85 days-99 days 6 0.33 mg/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85070 1602
SD blood aspartate aminotransferase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 71 days-85 days 6 136.8 U/l 11.03 27.01 automated blood analysis 0.0 0 Siemens biochemical analyzer 85072 1602
SD blood aspartate aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 71 days-85 days 6 263.17 U/l 34.35 84.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 85080 1602
SD blood alanine aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 85 days-99 days 6 46.73 U/l 8.3 20.33 automated blood analysis 0.0 0 Siemens biochemical analyzer 85087 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 190.7 g body weighing method 0.0 0 84789 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 264.0 g body weighing method 0.0 0 84793 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 136.2 g body weighing method 0.0 0 84794 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 156.6 g body weighing method 0.0 0 84796 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 172.8 g body weighing method 0.0 0 84798 1602
SD food intake rate acetaminophen (500 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 33.3 g/d unspecified method 0.0 0 84832 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 35.1 g/d unspecified method 0.0 0 84837 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 23.1 g/d unspecified method 0.0 0 84851 1602
SD food intake rate acetaminophen (500 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 19.9 g/d unspecified method 0.0 0 84856 1602
SD blood phosphate level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 71 days-85 days 6 5.98 mg/dl 0.33 0.82 automated blood analysis 0.0 0 Siemens biochemical analyzer 85163 1602
SD blood total cholesterol level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 71 days-85 days 6 78.0 mg/dl 2.9 7.1 automated blood analysis 0.0 0 Siemens biochemical analyzer 85167 1602
SD blood calcium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 85 days-99 days 6 7.03 mg/dl 1.67 4.1 automated blood analysis 0.0 0 Siemens biochemical analyzer 85148 1602
SD blood calcium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 71 days-85 days 6 9.95 mg/dl 0.08 0.19 automated blood analysis 0.0 0 Siemens biochemical analyzer 85149 1602
SD blood phosphate level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 71 days-85 days 6 5.9 mg/dl 0.18 0.43 automated blood analysis 0.0 0 Siemens biochemical analyzer 85158 1602
SD blood globulin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 85 days-99 days 6 2.5 g/dl 0.49 1.2 automated blood analysis 0.0 0 Siemens biochemical analyzer 85027 1602
SD blood globulin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 71 days-85 days 6 3.0 g/dl 0.02 0.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85030 1602
SD blood globulin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 85 days-99 days 6 3.0 g/dl 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85033 1602
SD blood aspartate aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 85 days-99 days 6 125.07 U/l 25.92 63.49 automated blood analysis 0.0 0 Siemens biochemical analyzer 85076 1602
SD blood alkaline phosphatase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 71 days-85 days 6 206.0 U/l 27.48 67.31 automated blood analysis 0.0 0 Siemens biochemical analyzer 85101 1602
SD blood alkaline phosphatase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 71 days-85 days 6 353.33 U/l 79.96 195.86 automated blood analysis 0.0 0 Siemens biochemical analyzer 85102 1602
SD blood bilirubin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 85 days-99 days 6 0.55 mg/dl 0.07 0.16 automated blood analysis 0.0 0 Siemens biochemical analyzer 85112 1602
SD blood bilirubin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 71 days-85 days 6 0.39 mg/dl 0.05 0.12 automated blood analysis 0.0 0 Siemens biochemical analyzer 85115 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 207.4 g body weighing method 0.0 0 84761 1602
SD body weight acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 150.9 g body weighing method 0.0 0 84811 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 35.8 g/d unspecified method 0.0 0 84826 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 31.9 g/d unspecified method 0.0 0 84827 1602
SD hematocrit acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 41.85 % 0.63 1.55 unspecified method 0.0 0 84960 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 33.6 g/d unspecified method 0.0 0 84847 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 160.5 g body weighing method 0.0 0 84818 1602
SD food intake rate acetaminophen (250 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 34.2 g/d unspecified method 0.0 0 84830 1602
SD blood differential white blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 71 days-85 days 6 6.56 x 1000 cells/ul 0.4 0.97 unspecified method 0.0 0 84885 1602
SD blood differential white blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 71 days-85 days 6 7.58 x 1000 cells/ul 0.55 1.34 unspecified method 0.0 0 84890 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 71 days-85 days 6 11.97 % 0.09 0.23 unspecified method 0.0 0 84965 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 85 days-99 days 6 11.73 % 0.18 0.44 unspecified method 0.0 0 84968 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait female 71 days-85 days 6 12.62 % 0.32 0.79 unspecified method 0.0 0 84971 1602
SD blood albumin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 85 days-99 days 6 2.48 g/dl 0.57 1.39 automated blood analysis 0.0 0 Siemens biochemical analyzer 85004 1602
SD blood triglyceride level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 71 days-85 days 6 109.5 mg/dl 30.43 74.55 automated blood analysis 0.0 0 Siemens biochemical analyzer 85181 1602
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.3 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 720 min 98787 2160
SD heart rate sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 380.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98802 2160
SD glomerular filtration rate to body weight ratio streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.68 ml/min/100g 0.02 0.06 inulin analysis by thiourea-resorcinol assay 0.0 stz 154 days 99903 2358
SD effective renal plasma flow streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.28 ml/min/100g 0.05 0.15 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days 99905 2358
SD percentage of study population developing anorectal malformation during a period of time in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. anorectal integrity trait male 1 days 0 0.0 % ex vivo light microscopy with histochemistry 1.0 0 anorectal malformation incidence 98734 2158
SD anogenital distance to cube root of body weight ratio in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. perineum length male 1 days 0 1.57 null 0.15 body measuring method 1.0 0 mm/g^1/3 98738 2158
SD blood urea nitrogen level controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood urea nitrogen amount male 140 days 6 17.7 mg/dl 1.3 3.18 blood urea nitrogen analysis 0.0 x 0 days 100152 2419
SD blood albumin level controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood albumin amount male 140 days 6 3.7 g/dl 0.1 0.24 automated blood albumin analysis 0.0 x 0 days 100160 2419
SD plasma angiotensin II level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin II amount male 120 days 3 50.0 pg/ml 11.55 20.0 enzyme immunoassay 0.0 0 100227 2439
SD serum creatinine level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood creatinine amount female 0 days 12 0.93 mg/dl 0.05 0.17 serum creatinine analysis 0.0 unx 97 days 100640 2499
SD creatinine clearance controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. glomerular filtration trait female 0 days 13 0.3 ml/min 0.03 0.11 serum creatinine analysis 0.0 unx 97 days 100642 2499
SD creatinine clearance controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. glomerular filtration trait female 0 days 10 0.35 ml/min 0.02 0.06 serum creatinine analysis 0.0 unx 97 days 100644 2499
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 14 129.0 s 18.44 69.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98199 2040
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 25 223.0 s 12.8 64.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98202 2040
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 19 222.0 s 9.18 40.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98203 2040
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 7.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 360 min 98818 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 13.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98826 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.1 null 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98866 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.3 null 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98872 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.6 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98874 2160
SD hematocrit control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. erythrocyte quantity male 90 days 9 46.0 % 1.0 3.0 hematocrit analysis 0.0 0 101220 2582
SD renal plasma flow control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney plasma flow trait male 420 days-450 days 9 5.73 ml/min 0.41 1.23 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 101229 2582
SD renal plasma flow to body weight ratio control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney plasma flow trait male 90 days 9 0.97 ml/min/100g 0.05 0.15 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 101230 2582
SD urine sodium excretion rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. urine sodium amount male 420 days-450 days 9 0.9 mEq/d 0.2 0.6 urine sodium analysis 0.0 0 101237 2582
SD adrenal gland weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 8 73.0 mg 2.83 8.0 post excision weight measurement 0.0 unx 28 days 101628 2602
SD kidney sclerotic glomeruli count to total glomeruli count ratio unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 8 31.0 % 5.66 16.0 ex vivo light microscopy with histochemistry 0.0 unx 28 days 101629 2602
SD adrenal gland weight sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 6 46.0 mg 0.82 2.0 post excision weight measurement 0.0 sham unx 28 days 101599 2602
SD adrenal gland weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 7 69.0 mg 3.4 9.0 post excision weight measurement 0.0 unx 28 days 101600 2602
SD left kidney wet weight sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 6 1.11 g 0.02 0.06 post excision weight measurement 0.0 sham unx 13 days remnant kidney 101543 2602
SD left kidney wet weight unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 11 1.37 g 0.07 0.23 post excision weight measurement 0.0 unx 13 days remnant kidney 101544 2602
SD urine total protein excretion rate sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 6 10.0 mg/d 0.82 2.0 urine protein analysis 0.0 sham unx 13 days 101551 2602
SD plasma aldosterone level unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood aldosterone amount male 0 days 5 487.0 pg/ml 50.98 114.0 plasma aldosterone analysis 0.0 unx 13 days 101558 2602
SD heart wet weight sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 6 1.03 g 0.02 0.05 post excision weight measurement 0.0 sham unx 28 days 101587 2602
SD urine total protein excretion rate unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 7 203.0 mg/d 38.93 103.0 urine protein analysis 0.0 unx 28 days 101592 2602
SD urine total protein excretion rate left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 70.0 mg/d 10.0 26.46 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98959 2179
SD urine total protein excretion rate left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 78.0 mg/d 12.0 36.0 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98960 2179
SD urine total protein excretion rate left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 127.0 mg/d 16.0 42.33 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98961 2179
SD urine protein level to urine creatinine level ratio left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 0.1 null 0.02 0.06 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 protein/creatinine 98963 2179
SD urine protein level to urine creatinine level ratio left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 0.1 null 0.02 0.05 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 98964 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 7.6 null 0.5 1.32 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98968 2179
SD left kidney wet weight control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 1.66 g 0.03 0.08 post excision weight measurement 0.0 0 99895 2358
SD body weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. body mass male 420 days-450 days 9 572.0 g 14.4 43.2 body weighing method 0.0 0 101215 2582
SD left kidney wet weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney mass male 90 days 9 1.22 g 0.05 0.15 post excision weight measurement 0.0 0 101216 2582
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98844 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.2 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98851 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98852 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98854 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98858 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98859 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.3 mm 0.1 0.24 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98862 2160
SD body weight left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 256.0 g 3.0 7.94 body weighing method 0.0 unx 0 98928 2179
SD mean arterial blood pressure left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 9 113.0 mmHg 5.0 15.0 tail cuff plethysmography 0.0 unx 0 98939 2179
SD mean arterial blood pressure left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 111.0 mmHg 4.0 10.58 tail cuff plethysmography 0.0 unx 0 98940 2179
SD mean arterial blood pressure left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 137.0 mmHg 10.0 26.46 tail cuff plethysmography 0.0 unx 70 days 98947 2179
SD urine total protein excretion rate left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 24.0 mg/d 2.0 6.0 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98954 2179
SD urine total protein excretion rate left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 78.0 mg/d 5.0 13.23 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98956 2179
SD urine total protein excretion rate left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 74.0 mg/d 8.0 24.0 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98957 2179
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 10 15.8 s 3.38 10.7 Morris water maze method 60.0 coronal plane rotational acceleration of the head 2 days time in platform 98245 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 1317.0 cm 257.03 727.0 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 30 days - 98247 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 1101.0 cm 204.0 612.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98250 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 777.0 cm 90.0 270.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98251 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 29.3 null 3.78 10.7 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 30 days 98252 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 11 10.1 s 1.66 5.5 Morris water maze method 60.0 coronal plane rotational acceleration of the head 31 days time to platform 98270 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 10.5 s 1.13 3.4 Morris water maze method 60.0 coronal plane rotational acceleration of the head 31 days time in platform 98276 2040
SD heart weight to body weight ratio artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.9 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98781 2160
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 21 29.7 null 1.94 8.9 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98218 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 14 954.0 cm 107.97 404.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98211 2040
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 39.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99369 2278
SD ejection fraction artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 79.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99374 2278
SD blood glucose level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood glucose amount male 140 days 8 137.7 mg/dl 8.3 23.48 blood glucose analysis 0.0 unx 84 days 100122 2419
SD blood hemoglobin A1c level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood hemoglobin amount male 140 days 6 3.3 % 0.1 0.24 blood hemoglobin analysis 0.0 unx 84 days 100132 2419
SD creatinine clearance nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. glomerular filtration trait male 140 days 6 2.3 ml/min 0.3 0.73 urine creatinine analysis 0.0 unx 84 days 100140 2419
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 14 18.0 s 4.2 15.7 Morris water maze method 60.0 coronal plane rotational acceleration of the head 3 days time to platform 98234 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 23 37.8 s 2.61 12.5 Morris water maze method 60.0 coronal plane rotational acceleration of the head 1 days time to platform 98238 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 23 50.7 s 4.82 23.1 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days time in open arms 98225 2040
SD body weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 98 days 8 354.0 g 9.0 25.46 scale 0.0 ACF 28 days 99192 2278
SD heart weight sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 1.26 g 0.03 0.09 post excision weight measurement 0.0 sham ACF 105 days 99197 2278
SD heart weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 4.4 g/kg 0.2 0.57 post excision weight measurement 0.0 ACF 28 days 99200 2278
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 98 days 8 2.1 mg/g 0.1 0.28 post excision weight measurement 0.0 sham ACF 28 days 99203 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 175 days 10 3.1 mg/g 0.1 0.32 post excision weight measurement 0.0 ACF 105 days 99206 2278
SD mean arterial blood pressure sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 175 days 10 95.0 mmHg 4.0 12.65 vascular transducer tipped catheter 0.0 sham ACF 105 days 99221 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 7.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99224 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -7479.0 mmHg/s 337.0 953.18 vascular transducer tipped catheter 0.0 sham ACF 28 days 99231 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 175 days 10 5.6 mm 0.1 0.32 echocardiography 0.0 sham ACF 105 days 99241 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 4.8 null 0.3 0.85 echocardiography 0.0 sham ACF 28 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99243 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 16.0 g/cm2 1.0 3.16 echocardiography 0.0 ACF 105 days 99250 2278
SD heart left ventricle interstitial angiotensin II level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 98 days 9 3.0 pg/hr 0.4 1.2 radioimmunoassay 0.0 ACF 28 days heart left ventricle interstitial angiotensin II level during a period of time 99260 2278
SD heart left ventricle interstitial bradykinin level during a period of time sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 175 days 8 7.4 pg/hr 1.4 3.96 radioimmunoassay 0.0 sham ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99265 2278
SD heart left ventricle interstitial epinephrine level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 175 days 10 8.6 pg/hr 1.1 3.48 enzyme linked immunosorbent assay 0.0 ACF 105 days heart left ventricle interstitial epinephrine level during a period of time 99274 2278
SD plasma angiotensin II level sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 98 days 8 29.0 pg/ml 3.0 8.49 radioimmunoassay 0.0 sham ACF 28 days 99275 2278
SD plasma angiotensin II level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 98 days 9 107.0 pg/ml 7.0 21.0 radioimmunoassay 0.0 ACF 28 days 99276 2278
SD plasma epinephrine level sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 98 days 8 83.0 pg/ml 12.0 33.94 enzyme linked immunosorbent assay 0.0 sham ACF 28 days 99287 2278
SD heart rate sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 7 321.0 beats/min 7.0 18.52 vascular transducer tipped catheter 0.0 sham ACF 28 days 99295 2278
SD mean arterial blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 7 107.0 mmHg 3.0 7.94 vascular transducer tipped catheter 0.0 sham ACF 28 days 99303 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 11.0 mmHg 1.0 2.24 vascular transducer tipped catheter 0.0 ACF 2 days 99308 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 10.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99314 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 57.0 mmHg 4.0 8.94 vascular transducer tipped catheter 0.0 ACF 2 days 99318 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 9065.0 mmHg/s 354.0 791.57 vascular transducer tipped catheter 0.0 ACF 2 days 99326 2278
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 7.7 mm 0.2 0.53 echocardiography 0.0 sham ACF 28 days 99343 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.2 mm 0.2 0.57 echocardiography 0.0 ACF 28 days 99346 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.0 mm 0.2 0.45 echocardiography 0.0 ACF 2 days 99350 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 7 4.7 mm 0.2 0.53 echocardiography 0.0 sham ACF 28 days 99351 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 6.0 null 0.4 1.13 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99362 2278
SD heart weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77 days 6 1.25 g 0.02 0.05 ex vivo method 0.0 lad occlusion 28 days 101079 2564
SD heart weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189 days 10 1.57 g 0.06 0.19 ex vivo method 0.0 lad occlusion 140 days 101081 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189 days 10 1.53 mg/g 0.04 0.13 ex vivo method 0.0 lad occlusion 140 days 101097 2564
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189 days 6 1.44 mg/g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 140 days 101098 2564
SD heart right ventricle weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77 days 6 0.23 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days 101100 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77 days 6 0.1 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days law/bw 101111 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101117 2564
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 21 75.6 s 8.58 39.3 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days time in open arms 98224 2040
SD ejection fraction sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 7 66.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99375 2278
SD left ventricle end-diastolic wall stress sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 4.0 g/cm2 1.0 2.65 echocardiography 0.0 sham ACF 28 days 99391 2278
SD left ventricle end-systolic wall stress sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 50.0 g/cm2 3.0 6.71 echocardiography 0.0 sham ACF 2 days lves-ws 99395 2278
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.3 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days GFR by inulin method 99911 2358
SD left kidney wet weight streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 2.18 g 0.05 0.14 post excision weight measurement 0.0 stz 224 days 99917 2358
SD blood glucose level streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 358.0 mg/dl 20.86 59.0 blood glucose analysis 0.0 stz 224 days 99920 2358
SD blood glucose level streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 350.0 mg/dl 19.09 54.0 blood glucose analysis 0.0 stz 224 days 99921 2358
SD systolic blood pressure streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 128.0 mmHg 1.06 3.0 tail cuff plethysmography 0.0 stz 224 days 99924 2358
SD glomerular filtration rate to body weight ratio streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.67 ml/min/100g 0.03 0.08 inulin analysis by thiourea-resorcinol assay 0.0 stz 224 days 99926 2358
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days GFR by inulin method 99933 2358
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 60 days 5 mean of 3 samples - 1 per minute serial mean 123.0 mmHg 2.68 6.0 tail cuff plethysmography 0.0 0 100168 2439
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 120 days 1 mean of 3 samples - 1 per minute serial mean 121.0 mmHg tail cuff plethysmography 0.0 0 100188 2439
SD creatinine clearance control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. glomerular filtration trait male 120 days 3 0.0 ml/min 0.0 0.0 urine creatinine analysis 0.0 0 100212 2439
SD plasma angiotensin I level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin I amount male 120 days 3 180.0 pg/ml 80.83 140.0 enzyme immunoassay 0.0 0 100221 2439
SD retinal uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 212.0 % 13.0 22.52 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106114 3028
SD retinal uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 336.0 % 7.0 12.12 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106120 3028
SD aqueous humor uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 5.95 % 0.38 0.66 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106132 3028
SD brain uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 0.99 % 0.35 0.61 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106153 3028
SD brain uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and digoxin (0.01 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 1.18 % 0.2 0.35 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106154 3028
SD brain uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 77.7 % 7.2 12.47 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106158 3028
SD the first 120min of plasma nifedipine level area under curve nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. blood xenobiotic amount both 56 days 6 26979.23 min x (ng/ml) 1522.03 3728.2 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling min x ng/ml 105710 3020
SD verapamil apparent influx permeability clearance in aqueous humor tritiated verapamil (10 uCi) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 0.0 ml/min/g 0.0 0.0 liquid scintillation counting 0.0 carotid injection 15 sec post excision ml/(min x g) 106103 3028
SD plasma nifedipine clearance nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. xenobiotic pharmacokinetics trait both 56 days 6 6.67 ml/min/kg 0.51 1.25 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling cl nifidepine 105716 3020
SD serum interleukin-4 level control condition Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-4 amount not specified 0 days 8 0.04 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105410 3015
SD serum interleukin-4 level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-4 amount not specified 0 days 12 0.05 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105412 3015
SD serum interleukin-4 level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-4 amount not specified 0 days 12 0.15 ug/l 0.01 0.02 enzyme linked immunosorbent assay 0.0 0 error not defined 105413 3015
SD intestine trypsin level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. intestine trypsin amount not specified 0 days 12 0.11 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105420 3015
SD body weight doxorubicin (5 mg/kg) (between 6 and 7 days) Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. body mass female 96 days-121 days 7 192.0 g 2.65 7.0 body weighing method 0.0 0 110178 3166
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 180.4 g body weighing method 0.0 0 84760 1602
SD body weight acetaminophen (250 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 244.0 g body weighing method 0.0 0 84768 1602
SD body weight acetaminophen (500 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 181.7 g body weighing method 0.0 0 84770 1602
SD food intake rate acetaminophen (500 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 21.6 g/d unspecified method 0.0 0 84857 1602
SD blood urea nitrogen level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 71 days-85 days 6 14.2 mg/dl 0.31 0.75 automated blood analysis 0.0 0 Siemens biochemical analyzer 85037 1602
SD blood albumin level to blood globulin level ratio control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 85 days-99 days 6 0.77 null 0.15 0.36 automated blood analysis 0.0 0 Siemens biochemical analyzer 85051 1602
SD blood creatinine level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 71 days-85 days 6 0.5 mg/dl 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85059 1602
SD blood aspartate aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 71 days-85 days 6 169.7 U/l 11.38 27.88 automated blood analysis 0.0 0 Siemens biochemical analyzer 85071 1602
SD blood aspartate aminotransferase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 71 days-85 days 6 140.8 U/l 8.19 20.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85073 1602
SD blood aspartate aminotransferase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 71 days-85 days 6 118.67 U/l 12.26 30.03 automated blood analysis 0.0 0 Siemens biochemical analyzer 85078 1602
SD blood alanine aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 71 days-85 days 6 54.0 U/l 2.2 5.4 automated blood analysis 0.0 0 Siemens biochemical analyzer 85086 1602
SD blood bilirubin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 71 days-85 days 6 0.41 mg/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85109 1602
SD blood phosphate level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 71 days-85 days 6 6.3 mg/dl 0.07 0.18 automated blood analysis 0.0 0 Siemens biochemical analyzer 85155 1602
SD blood total cholesterol level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 85 days-99 days 6 73.99 mg/dl 12.53 30.68 automated blood analysis 0.0 0 Siemens biochemical analyzer 85171 1602
SD blood total cholesterol level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 71 days-85 days 6 102.5 mg/dl 1.84 4.51 automated blood analysis 0.0 0 Siemens biochemical analyzer 85173 1602
SD liver wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 71 days-85 days 6 4.2 g 0.12 0.3 post excision weight measurement 0.0 0 85202 1602
SD both kidneys wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 71 days-85 days 6 0.89 g 0.03 0.08 post excision weight measurement 0.0 0 85206 1602
SD brain wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 71 days-85 days 6 0.75 g 0.02 0.06 post excision weight measurement 0.0 0 85257 1602
SD brain wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 71 days-85 days 6 1.1 g 0.02 0.04 post excision weight measurement 0.0 0 85260 1602
SD adrenal gland wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 85 days-99 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85271 1602
SD uterus wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 71 days-85 days 6 0.38 g 0.04 0.1 post excision weight measurement 0.0 0 85287 1602
SD red blood cell distribution width-coefficient of variation control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait female 71 days-85 days 6 10.98 % 0.32 0.78 unspecified method 0.0 0 84969 1602
SD platelet count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 85 days-99 days 6 1122.17 x 1000 cells/ul 129.6 317.45 unspecified method 0.0 0 84980 1602
SD platelet count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 85 days-99 days 6 846.0 x 1000 cells/ul 35.44 86.81 unspecified method 0.0 0 84985 1602
SD blood potassium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 85 days-99 days 6 4.77 mmol/l 0.06 0.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85142 1602
SD blood triglyceride level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 71 days-85 days 6 22.8 mg/dl 2.33 5.71 automated blood analysis 0.0 0 Siemens biochemical analyzer 85185 1602
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 81.0 g/cm2 8.0 22.63 echocardiography 0.0 ACF 28 days 99400 2278
SD heart rate sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 385.0 beats/min 11.0 26.94 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98794 2160
SD heart rate artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 420.0 beats/min 14.0 34.29 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98801 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 71.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98810 2160
SD verapamil equilibrated distribution volume in retina tritiated verapamil (10 uCi) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 3.32 ml/g 0.2 0.34 liquid scintillation counting 0.0 carotid injection 15 sec post excision 106108 3028
SD aqueous humor uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 8.46 % 0.61 1.06 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106138 3028
SD blood calcium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 85 days-99 days 6 8.27 mg/dl 1.63 4.0 automated blood analysis 0.0 0 Siemens biochemical analyzer 85147 1602
SD blood calcium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 71 days-85 days 6 10.42 mg/dl 0.13 0.31 automated blood analysis 0.0 0 Siemens biochemical analyzer 85152 1602
SD body weight controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 12 281.9 g 4.2 14.55 body weighing method 0.0 unx 97 days 100633 2499
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 2.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 sham ACF 2 days 98823 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 61.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98832 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 56.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98834 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 57.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98840 2160
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.5 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 2 days 98877 2160
SD body weight sham surgical control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 282.0 g 16.0 39.19 body weighing method 1.0 sham ACF 2 days 98774 2160
SD body weight sham surgical control condition (between 120 and 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 284.0 g 4.0 9.8 body weighing method 1.0 sham ACF 5 days 98776 2160
SD heart weight to body weight ratio sham surgical control condition (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.4 g/kg 0.1 0.24 post excision weight measurement 1.0 sham ACF 720 min 98780 2160
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 6971.0 mmHg/s 438.0 1072.88 vascular transducer tipped catheter 1.0 ACF 2 days 98888 2160
SD systolic blood pressure unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 5 undefined 125.0 mmHg 6.26 14.0 tail cuff plethysmography 0.0 unx 13 days 101549 2602
SD plasma potassium level unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 6 4.5 mmol/l 0.2 0.5 ex vivo blood analysis 0.0 unx 28 days 101598 2602
SD plasma norepinephrine level sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 175 days 8 102.0 pg/ml 16.0 45.25 enzyme linked immunosorbent assay 0.0 sham ACF 105 days 99285 2278
SD plasma epinephrine level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 98 days 9 91.0 pg/ml 21.0 63.0 enzyme linked immunosorbent assay 0.0 ACF 28 days 99288 2278
SD heart rate sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 371.0 beats/min 4.0 8.94 vascular transducer tipped catheter 0.0 sham ACF 2 days 99293 2278
SD mean arterial blood pressure sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 100.0 mmHg 2.0 4.47 vascular transducer tipped catheter 0.0 sham ACF 2 days 99299 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 90.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99304 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 10.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99312 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8116.0 mmHg/s 348.0 984.29 vascular transducer tipped catheter 0.0 ACF 28 days 99328 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.8 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99352 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 lvedd/pw 4.5 null 0.4 1.06 echocardiography 0.0 sham ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99361 2278
SD food intake rate acetaminophen (250 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 32.5 g/d unspecified method 0.0 0 84828 1602
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189 days 10 0.52 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101105 2564
SD left atrium weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189 days 6 0.04 g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 140 days 101110 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189 days 10 0.09 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days raw/bw 101121 2564
SD body weight left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 9 258.0 g 3.0 9.0 body weighing method 0.0 unx 0 98927 2179
SD body weight left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 318.0 g 15.0 39.69 body weighing method 0.0 unx 56 days 98932 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 6.4 null 1.1 3.3 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98969 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 13.3 null 1.7 4.5 urine protein sulfosalicylic acid precipitation test 0.0 unx 70 days 98973 2179
SD left ventricle end-systolic wall stress sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 68.0 g/cm2 8.0 21.17 echocardiography 0.0 sham ACF 28 days 99401 2278
SD hematocrit control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 45.25 % 0.57 1.39 unspecified method 0.0 0 84951 1602
SD hematocrit acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 45.1 % 0.49 1.2 unspecified method 0.0 0 84954 1602
SD hematocrit acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 40.85 % 0.51 1.24 unspecified method 0.0 0 84959 1602
SD heart wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 85 days-99 days 6 0.33 g 0.02 0.05 post excision weight measurement 0.0 0 85234 1602
SD spleen wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 71 days-85 days 6 0.22 g 0.01 0.03 post excision weight measurement 0.0 0 85242 1602
SD spleen wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 71 days-85 days 6 0.21 g 0.01 0.02 post excision weight measurement 0.0 0 85245 1602
SD brain wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 85 days-99 days 6 0.67 g 0.01 0.03 post excision weight measurement 0.0 0 85258 1602
SD adrenal gland wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 71 days-85 days 6 0.04 g 0.0 0.01 post excision weight measurement 0.0 0 85274 1602
SD uterus wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 85 days-99 days 6 0.35 g 0.02 0.05 post excision weight measurement 0.0 0 85288 1602
SD blood bilirubin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 71 days-85 days 6 0.44 mg/dl 0.05 0.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 85113 1602
SD blood sodium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 71 days-85 days 6 147.8 mmol/l 0.7 1.72 automated blood analysis 0.0 0 Siemens biochemical analyzer 85122 1602
SD blood sodium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 85 days-99 days 6 104.23 mmol/l 24.73 60.57 automated blood analysis 0.0 0 Siemens biochemical analyzer 85124 1602
SD blood glucose level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 71 days-85 days 6 181.5 mg/dl 3.6 8.83 automated blood analysis 0.0 0 Siemens biochemical analyzer 84996 1602
SD plasma total protein level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 71 days-85 days 6 65.0 mg/ml 0.94 2.3 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85014 1602
SD plasma total protein level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 71 days-85 days 6 64.0 mg/ml 1.39 3.4 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85018 1602
SD blood creatinine level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 71 days-85 days 6 0.4 mg/dl 0.02 0.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85060 1602
SD blood creatinine level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 85 days-99 days 6 0.37 mg/dl 0.07 0.16 automated blood analysis 0.0 0 Siemens biochemical analyzer 85063 1602
SD blood creatinine level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 71 days-85 days 6 0.4 mg/dl 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85065 1602
SD blood aspartate aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 71 days-85 days 6 162.23 U/l 8.83 21.64 automated blood analysis 0.0 0 Siemens biochemical analyzer 85077 1602
SD blood aspartate aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 85 days-99 days 6 146.5 U/l 7.35 18.01 automated blood analysis 0.0 0 Siemens biochemical analyzer 85082 1602
SD blood alanine aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 85 days-99 days 6 49.67 U/l 2.17 5.32 automated blood analysis 0.0 0 Siemens biochemical analyzer 85093 1602
SD blood alkaline phosphatase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 85 days-99 days 6 268.14 U/l 48.98 119.97 automated blood analysis 0.0 0 Siemens biochemical analyzer 85099 1602
SD blood bilirubin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 71 days-85 days 6 0.41 mg/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85108 1602
SD body weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 258.5 g body weighing method 0.0 0 84769 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 182.4 g body weighing method 0.0 0 84775 1602
SD body weight acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 231.9 g body weighing method 0.0 0 84791 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 148.3 g body weighing method 0.0 0 84795 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 167.0 g body weighing method 0.0 0 84797 1602
SD body weight acetaminophen (250 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 152.8 g body weighing method 0.0 0 84800 1602
SD body weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 162.5 g body weighing method 0.0 0 84808 1602
SD food intake rate acetaminophen (500 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 39.4 g/d unspecified method 0.0 0 84834 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 31.0 g/d unspecified method 0.0 0 84839 1602
SD blood potassium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 71 days-85 days 6 5.0 mmol/l 0.15 0.36 automated blood analysis 0.0 0 Siemens biochemical analyzer 85133 1602
SD blood potassium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 85 days-99 days 6 3.88 mmol/l 0.9 2.2 automated blood analysis 0.0 0 Siemens biochemical analyzer 85136 1602
SD blood potassium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 85 days-99 days 6 4.7 mmol/l 0.11 0.28 automated blood analysis 0.0 0 Siemens biochemical analyzer 85141 1602
SD blood triglyceride level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 71 days-85 days 6 31.7 mg/dl 2.0 4.89 automated blood analysis 0.0 0 Siemens biochemical analyzer 85188 1602
SD blood calcium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 71 days-85 days 6 10.0 mg/dl 0.1 0.25 automated blood analysis 0.0 0 Siemens biochemical analyzer 85143 1602
SD blood calcium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount male 71 days-85 days 6 9.9 mg/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85146 1602
SD blood total cholesterol level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 71 days-85 days 6 102.3 mg/dl 3.01 7.37 automated blood analysis 0.0 0 Siemens biochemical analyzer 85175 1602
SD body weight acetaminophen (500 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 241.1 g body weighing method 0.0 0 84773 1602
SD blood albumin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 3.3 g/dl 0.1 0.25 automated blood analysis 0.0 0 Siemens biochemical analyzer 85000 1602
SD plasma total protein level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 71 days-85 days 6 63.0 mg/ml 1.43 3.5 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85012 1602
SD blood globulin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 71 days-85 days 6 3.0 g/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85029 1602
SD blood bilirubin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 71 days-85 days 6 0.47 mg/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85110 1602
SD blood bilirubin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 71 days-85 days 6 1.33 mg/dl 0.2 0.49 automated blood analysis 0.0 0 Siemens biochemical analyzer 85116 1602
SD heart wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 71 days-85 days 6 0.37 g 0.01 0.02 post excision weight measurement 0.0 0 85231 1602
SD red blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 85 days-99 days 6 8.64 x 10E6 cells/ul 0.24 0.6 unspecified method 0.0 0 84899 1602
SD blood differential white blood cell count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 71 days-85 days 6 8.83 x 1000 cells/ul 1.33 3.25 unspecified method 0.0 0 84902 1602
SD red blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 8.97 x 10E6 cells/ul 0.2 0.5 unspecified method 0.0 0 84912 1602
SD hematocrit acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 40.22 % 0.83 2.03 unspecified method 0.0 0 84958 1602
SD hematocrit control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 85 days-99 days 6 39.8 % 0.63 1.55 unspecified method 0.0 0 84961 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 21.8 g/d unspecified method 0.0 0 84860 1602
SD both kidneys wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 71 days-85 days 6 0.88 g 0.03 0.07 post excision weight measurement 0.0 0 85214 1602
SD both lungs wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 71 days-85 days 6 0.73 g 0.09 0.23 post excision weight measurement 0.0 0 85218 1602
SD both lungs wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 85 days-99 days 6 0.66 g 0.06 0.14 post excision weight measurement 0.0 0 85222 1602
SD both lungs wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 71 days-85 days 6 0.8 g 0.03 0.07 post excision weight measurement 0.0 0 85226 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 184.1 g body weighing method 0.0 0 84781 1602
SD blood differential white blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 85 days-99 days 6 8.19 x 1000 cells/ul 0.53 1.31 unspecified method 0.0 0 84891 1602
SD blood differential white blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 85 days-99 days 6 8.34 x 1000 cells/ul 0.79 1.94 unspecified method 0.0 0 84893 1602
SD blood hemoglobin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 85 days-99 days 6 13.9 g/dl 0.2 0.5 unspecified method 0.0 0 84943 1602
SD blood hemoglobin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 71 days-85 days 6 11.57 g/dl 0.38 0.92 unspecified method 0.0 0 84946 1602
SD blood hemoglobin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 71 days-85 days 6 11.9 g/dl 0.16 0.4 unspecified method 0.0 0 84947 1602
SD platelet count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 71 days-85 days 6 816.0 x 1000 cells/ul 44.32 108.56 unspecified method 0.0 0 84981 1602
SD blood albumin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 3.3 g/dl 0.08 0.19 automated blood analysis 0.0 0 Siemens biochemical analyzer 85007 1602
SD blood albumin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 85 days-99 days 6 3.62 g/dl 0.04 0.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85010 1602
SD blood albumin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 3.5 g/dl 0.08 0.2 automated blood analysis 0.0 0 Siemens biochemical analyzer 85002 1602
SD systolic blood pressure controlled enalapril content drinking water (5 mg/kg/d) (for 10 days) Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 130 days 1 mean of 3 samples - 1 per minute serial mean 117.0 mmHg tail cuff plethysmography 0.0 0 102814 2439
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.2 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 360 min 98786 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.7 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 5 days 98791 2160
SD mean arterial blood pressure sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 76.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 sham ACF 2 days 98811 2160
SD mean arterial blood pressure sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 85.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 5 days 98813 2160
SD mean arterial blood pressure sham surgical control condition (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 82.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 2 days 98817 2160
SD creatinine clearance left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. glomerular filtration trait male 0 days 7 0.44 ml/min 0.11 0.29 serum creatinine analysis 0.0 unx 70 days 98994 2179
SD creatinine clearance left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. glomerular filtration trait male 0 days 7 1.34 ml/min 0.3 0.79 automated serum creatinine analysis 0.0 unx 70 days 98996 2179
SD glomerular filtration rate to body weight ratio streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.67 ml/min/100g 0.02 0.06 inulin analysis by thiourea-resorcinol assay 0.0 stz 154 days 99902 2358
SD effective renal plasma flow control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.24 ml/min/100g 0.06 0.18 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 99907 2358
SD blood urea nitrogen level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood urea nitrogen amount male 140 days 6 34.2 mg/dl 1.6 3.92 blood urea nitrogen analysis 0.0 unx 84 days 100154 2419
SD body weight control condition Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 8 305.4 g 5.3 14.99 body weighing method 0.0 - 0 days 100631 2499
SD body weight controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 10 291.9 g 6.4 20.24 body weighing method 0.0 unx 97 days 100634 2499
SD serum creatinine level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood creatinine amount female 0 days 10 1.5 mg/dl 0.11 0.35 serum creatinine analysis 0.0 unx 97 days 100639 2499
SD creatinine clearance control condition Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. glomerular filtration trait female 0 days 8 0.96 ml/min 0.07 0.2 serum creatinine analysis 0.0 - 0 days 100641 2499
SD serum parathyroid hormone level control condition Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood parathyroid hormone amount female 0 days 8 83.0 pg/ml 19.0 53.74 serum parathyroid hormone analysis 0.0 - 0 days 100646 2499
SD serum parathyroid hormone level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood parathyroid hormone amount female 0 days 10 629.0 pg/ml 208.0 657.75 serum parathyroid hormone analysis 0.0 unx 97 days 100649 2499
SD serum parathyroid hormone level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood parathyroid hormone amount female 0 days 12 170.0 pg/ml 60.0 207.85 serum parathyroid hormone analysis 0.0 unx 97 days 100650 2499
SD change in body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 59.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101609 2602
SD left kidney wet weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 8 1.96 g 0.16 0.44 post excision weight measurement 0.0 unx 28 days 101613 2602
SD left kidney wet weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 8 1.79 g 0.12 0.35 post excision weight measurement 0.0 unx 28 days 101614 2602
SD urine total protein excretion rate unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 8 130.0 mg/d 19.09 54.0 urine protein analysis 0.0 unx 14 days 101622 2602
SD urine total protein excretion rate unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 8 283.0 mg/d 52.33 148.0 urine protein analysis 0.0 unx 28 days 101623 2602
SD plasma potassium level unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 8 5.2 mmol/l 0.14 0.4 ex vivo blood analysis 0.0 unx 14 days 101626 2602
SD kidney sclerotic glomeruli count to total glomeruli count ratio unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 6 25.3 % 4.53 11.1 ex vivo light microscopy with histochemistry 0.0 unx 28 days 101606 2602
SD body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 285.0 g 6.71 15.0 body weighing method 0.0 unx 13 days 101537 2602
SD change in body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 74.0 g 7.6 17.0 body weighing method 0.0 unx 13 days change from surgery weight 101541 2602
SD change in body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 66.0 g 4.92 11.0 body weighing method 0.0 unx 13 days change from surgery weight 101542 2602
SD urine total protein excretion rate unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 11 121.0 mg/d 16.28 54.0 urine protein analysis 0.0 unx 13 days - 101552 2602
SD urine total protein excretion rate unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 5 31.0 mg/d 5.37 12.0 urine protein analysis 0.0 unx 13 days 101553 2602
SD adrenal gland weight unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 11 63.0 mg 1.21 4.0 post excision weight measurement 0.0 unx 13 days - 101560 2602
SD plasma renin activity level unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. renin activity male 0 days 11 4.3 ng/ml/h 0.63 2.08 radioimmunoassay 0.0 unx 13 days - 101564 2602
SD body weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 312.0 g 9.8 24.0 body weighing method 0.0 unx 28 days 101574 2602
SD change in body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 7 96.0 g 15.12 40.0 body weighing method 0.0 unx 28 days change from surgery weight 101576 2602
SD left kidney wet weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 7 1.91 g 0.21 0.55 post excision weight measurement 0.0 unx 28 days remnant kidney 101580 2602
SD systolic blood pressure sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 6 undefined 118.0 mmHg 4.08 10.0 tail cuff plethysmography 0.0 sham unx 28 days 101583 2602
SD systolic blood pressure unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 7 undefined 212.0 mmHg 7.56 20.0 tail cuff plethysmography 0.0 unx 28 days 101584 2602
SD systolic blood pressure unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 7 undefined 109.0 mmHg 4.16 11.0 tail cuff plethysmography 0.0 unx 28 days 101585 2602
SD urine total protein excretion rate unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 6 217.0 mg/d 28.99 71.0 urine protein analysis 0.0 unx 28 days 101594 2602
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 7.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 5 days 98824 2160
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 3.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 sham ACF 2 days 98829 2160
SD left ventricular end-systolic blood pressure sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 66.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 2 days 98835 2160
SD ejection fraction artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 66.0 % 4.0 9.8 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98880 2160
SD ejection fraction sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 65.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98883 2160
SD body weight streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 526.0 g 10.25 29.0 body weighing method 0.0 stz 154 days 99871 2358
SD mean arterial blood pressure control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. arterial blood pressure trait male 420 days-450 days 9 123.0 mmHg 12.0 36.0 vascular fluid filled catheter 0.0 0 101223 2582
SD renal plasma flow control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney plasma flow trait male 90 days 9 3.83 ml/min 0.21 0.63 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 101228 2582
SD urine sodium excretion rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. urine sodium amount male 90 days 9 1.4 mEq/d 0.4 1.2 urine sodium analysis 0.0 0 101236 2582
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 23 21.3 s 3.9 18.7 Morris water maze method 60.0 coronal plane rotational acceleration of the head 2 days time to platform 98239 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 23 18.9 s 3.13 15.0 Morris water maze method 60.0 coronal plane rotational acceleration of the head 3 days time to platform 98240 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 10 15.2 s 2.75 8.7 Morris water maze method 60.0 coronal plane rotational acceleration of the head 3 days time in platform 98246 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 17 23.1 null 2.69 11.1 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98253 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 11 1168.0 null 109.45 363.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98254 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 18.4 null 2.83 8.5 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98256 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 11 90.8 s 10.64 35.3 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days time in open arms 98259 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 31.0 s 5.13 15.4 Morris water maze method 60.0 coronal plane rotational acceleration of the head 29 days time in platform 98274 2040
SD body weight artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 267.0 g 4.0 9.8 body weighing method 1.0 ACF 720 min 98771 2160
SD heart weight to body weight ratio sham surgical control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.3 g/kg 0.1 0.24 post excision weight measurement 1.0 sham ACF 2 days 98782 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.3 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98845 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98847 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98849 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98850 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.0 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98855 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.9 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98857 2160
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 8231.0 mmHg/s 423.0 1036.13 vascular transducer tipped catheter 1.0 sham ACF 2 days 98887 2160
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -6032.0 mmHg/s 387.0 947.95 vascular transducer tipped catheter 1.0 ACF 2 days 98890 2160
SD body weight left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 267.0 g 7.0 18.52 body weighing method 0.0 unx 70 days 98935 2179
SD body weight left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 9 281.0 g 15.0 45.0 body weighing method 0.0 unx 70 days 98936 2179
SD mean arterial blood pressure left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 148.0 mmHg 4.0 10.58 tail cuff plethysmography 0.0 unx 28 days 98943 2179
SD mean arterial blood pressure left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 9 153.0 mmHg 8.0 24.0 tail cuff plethysmography 0.0 unx 56 days 98945 2179
SD urine total protein excretion rate left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 9 0.7 mg/d 0.1 0.3 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 98951 2179
SD urine total protein excretion rate left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 0.9 mg/d 0.1 0.26 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 98952 2179
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 23 1131.0 cm 81.74 392.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98213 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 10 1334.0 cm 84.43 267.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98215 2040
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 50.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99366 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 37.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99368 2278
SD ejection fraction sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 72.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days 99373 2278
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 42.2 s 10.47 29.6 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 2 days time in open arms 98222 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 10 98.1 s 9.42 29.8 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days time in open arms 98227 2040
SD body weight sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 98 days 8 359.0 g 20.0 56.57 scale 0.0 sham ACF 28 days 99191 2278
SD body weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 175 days 10 489.0 g 15.0 47.43 scale 0.0 ACF 105 days 99194 2278
SD heart weight to body weight ratio sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 2.7 g/kg 0.1 0.32 post excision weight measurement 0.0 sham ACF 105 days 99201 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 98 days 8 3.1 mg/g 0.1 0.28 post excision weight measurement 0.0 ACF 28 days 99204 2278
SD heart right ventricle weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 98 days 8 0.9 mg/g 0.1 0.28 post excision weight measurement 0.0 ACF 28 days 99208 2278
SD lung weight sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 98 days 8 1.46 g 0.09 0.25 post excision weight measurement 0.0 sham ACF 28 days 99211 2278
SD lung weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 175 days 10 2.44 g 0.11 0.35 post excision weight measurement 0.0 ACF 105 days 99214 2278
SD mean arterial blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 114.0 mmHg 4.0 11.31 vascular transducer tipped catheter 0.0 sham ACF 28 days 99219 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 95.0 mmHg 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99220 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 2.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 sham ACF 28 days 99223 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 6600.0 mmHg/s 289.0 913.9 vascular transducer tipped catheter 0.0 ACF 105 days 99230 2278
SD systolic blood pressure nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. arterial blood pressure trait male 140 days 6 serial mean 142.8 mmHg 6.4 15.68 tail cuff plethysmography 0.0 unx 84 days 100114 2419
SD blood glucose level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood glucose amount male 140 days 6 138.6 mg/dl 10.3 25.23 blood glucose analysis 0.0 unx 84 days 100124 2419
SD blood hemoglobin A1c level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood hemoglobin amount male 140 days 6 3.2 % 0.1 0.24 blood hemoglobin analysis 0.0 unx 84 days 100128 2419
SD blood hemoglobin A1c level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood hemoglobin amount male 140 days 8 3.2 % 0.1 0.28 tail cuff plethysmography 0.0 unx 84 days 100130 2419
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 14 37.5 s 3.02 11.3 Morris water maze method 60.0 coronal plane rotational acceleration of the head 1 days time to platform 98232 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 14 15.8 s 2.89 10.8 Morris water maze method 60.0 coronal plane rotational acceleration of the head 2 days time to platform 98233 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 21 23.1 s 3.58 16.4 Morris water maze method 60.0 coronal plane rotational acceleration of the head 2 days time to platform 98236 2040
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -6995.0 mmHg/s 458.0 1295.42 vascular transducer tipped catheter 0.0 ACF 28 days 99232 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 -5401.0 mmHg/s 358.0 1132.1 vascular transducer tipped catheter 0.0 sham ACF 105 days 99233 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 -4244.0 mmHg/s 222.0 702.03 vascular transducer tipped catheter 0.0 ACF 105 days 99234 2278
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 9.0 mm 0.1 0.32 echocardiography 0.0 sham ACF 105 days 99237 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 11.6 mm 0.4 1.26 echocardiography 0.0 ACF 105 days 99238 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.3 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99240 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 lvedd/pw 7.9 null 0.4 1.26 echocardiography 0.0 ACF 105 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99246 2278
SD left ventricle end-diastolic wall stress sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 3.0 g/cm2 1.0 2.83 echocardiography 0.0 sham ACF 28 days 99247 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 14.0 g/cm2 3.0 8.49 echocardiography 0.0 ACF 28 days 99248 2278
SD left ventricle end-systolic wall stress sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 67.0 g/cm2 13.0 36.77 echocardiography 0.0 sham ACF 28 days 99251 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 38.0 % 4.0 11.31 echocardiography 0.0 sham ACF 28 days 99255 2278
SD heart left ventricle interstitial angiotensin II level during a period of time sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 98 days 8 1.5 pg/hr 0.2 0.57 radioimmunoassay 0.0 sham ACF 28 days heart left ventricle interstitial angiotensin II level during a period of time 99259 2278
SD heart left ventricle interstitial bradykinin level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 98 days 9 9.3 pg/hr 1.1 3.3 radioimmunoassay 0.0 ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99264 2278
SD heart left ventricle interstitial epinephrine level during a period of time sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 98 days 8 3.5 pg/hr 0.3 0.85 enzyme linked immunosorbent assay 0.0 sham ACF 28 days heart left ventricle interstitial epinephrine level during a period of time 99271 2278
SD heart left ventricle interstitial epinephrine level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 98 days 9 5.3 pg/hr 0.9 2.7 enzyme linked immunosorbent assay 0.0 ACF 28 days heart left ventricle interstitial epinephrine level during a period of time 99272 2278
SD heart left ventricle interstitial epinephrine level during a period of time sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 175 days 8 3.5 pg/hr 0.4 1.13 enzyme linked immunosorbent assay 0.0 sham ACF 105 days heart left ventricle interstitial epinephrine level during a period of time 99273 2278
SD plasma angiotensin II level sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 175 days 8 34.0 pg/ml 4.0 11.31 radioimmunoassay 0.0 sham ACF 105 days 99277 2278
SD plasma angiotensin II level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 175 days 10 65.0 pg/ml 13.0 41.11 radioimmunoassay 0.0 ACF 105 days 99278 2278
SD plasma norepinephrine level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 175 days 10 159.0 pg/ml 17.0 53.76 enzyme linked immunosorbent assay 0.0 ACF 105 days 99286 2278
SD heart rate artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 367.0 beats/min 8.0 17.89 vascular transducer tipped catheter 0.0 ACF 2 days 99292 2278
SD heart rate artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 375.0 beats/min 12.0 26.83 vascular transducer tipped catheter 0.0 ACF 2 days 99294 2278
SD heart rate artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 316.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99298 2278
SD mean arterial blood pressure sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 7 106.0 mmHg 5.0 13.23 vascular transducer tipped catheter 0.0 sham ACF 28 days 99305 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 86.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99306 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 61.0 mmHg 3.0 6.71 vascular transducer tipped catheter 0.0 ACF 2 days 99316 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -6834.0 mmHg/s 333.0 941.87 vascular transducer tipped catheter 0.0 ACF 28 days 99337 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 7 4.7 mm 0.2 0.53 echocardiography 0.0 sham ACF 28 days 99353 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 5.7 null 0.3 0.85 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99360 2278
SD body weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 77 days 6 378.1 g 12.1 29.64 body weighing method 0.0 sham lad occlusion 28 days 101076 2564
SD systolic blood pressure left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 77 days 6 undefined 125.0 mmHg 3.0 7.35 tail cuff plethysmography 0.0 lad occlusion 28 days 101087 2564
SD systolic blood pressure sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 189 days 6 undefined 144.0 mmHg 2.0 4.9 tail cuff plethysmography 0.0 sham lad occlusion 140 days 101090 2564
SD heart left ventricle weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77 days 6 0.6 g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 28 days 101092 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77 days 6 1.67 mg/g 0.04 0.1 ex vivo method 0.0 lad occlusion 28 days 101095 2564
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77 days 6 1.56 mg/g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 28 days 101096 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189 days 10 0.29 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101101 2564
SD heart right ventricle weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189 days 6 0.27 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 140 days 101102 2564
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77 days 6 0.59 mg/g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days 101104 2564
SD heart left ventricle infarction area to total heart left ventricle area ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle integrity trait male 77 days 6 35.4 % 1.9 4.65 ex vivo visual assessment 0.0 lad occlusion 28 days 101127 2564
SD heart left ventricle infarction area to total heart left ventricle area ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle integrity trait male 189 days 10 37.9 % 2.0 6.32 ex vivo visual assessment 0.0 lad occlusion 140 days 101128 2564
SD blood albumin level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood albumin amount male 140 days 6 3.2 g/dl 0.2 0.49 automated blood albumin analysis 0.0 unx 84 days 100165 2419
SD plasma urea nitrogen level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood urea nitrogen amount male 120 days 3 6.78 mmol/l 0.41 0.71 plasma urea nitrogen analysis 0.0 0 100200 2439
SD plasma urea nitrogen level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood urea nitrogen amount male 180 days 5 6.43 mmol/l 0.21 0.36 plasma urea nitrogen analysis 0.0 0 100202 2439
SD serum creatinine level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood creatinine amount male 120 days 3 0.55 mg/dl 0.01 0.01 serum creatinine analysis 0.0 0 100206 2439
SD serum creatinine level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood creatinine amount male 180 days 5 0.55 mg/dl 0.06 0.1 serum creatinine analysis 0.0 0 100208 2439
SD body weight sham surgical control condition (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 291.0 g 10.0 24.49 body weighing method 1.0 sham ACF 360 min 98756 2160
SD ejection fraction sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 7 67.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99377 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 16.0 g/cm2 1.0 2.24 echocardiography 0.0 ACF 2 days 99388 2278
SD left ventricle end-diastolic wall stress sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 4.0 g/cm2 1.0 2.65 echocardiography 0.0 sham ACF 28 days 99393 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 7 3.5 % 0.1 0.26 ex vivo light microscopy with histochemistry and digital image analysis 0.0 sham ACF 28 days 99407 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 8 3.5 % 0.1 0.28 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 28 days 99409 2278
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days GFR by inulin method 99912 2358
SD body weight streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 588.0 g 27.58 78.0 body weighing method 0.0 stz 224 days 99914 2358
SD plasma nifedipine level nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. blood xenobiotic amount both 56 days 6 926.52 ng/ml 142.87 349.96 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling intial concentration nifidepine 105708 3020
SD retinal uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and digoxin (0.01 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 26.3 % 5.7 9.87 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106118 3028
SD brain uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 9.07 % 0.89 1.54 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106156 3028
SD aqueous humor uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vinblastine (1 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 15.7 % 1.0 1.73 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106139 3028
SD aqueous humor uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 23.1 % 6.4 11.09 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106140 3028
SD serum total immunoglobulin E level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood immunoglobulin E amount not specified 0 days 12 0.1 ug/l 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 error not defined 105408 3015
SD serum interleukin-4 level vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-4 amount not specified 0 days 4 0.14 ug/l 0.01 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105411 3015
SD intestine trypsin level control condition Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. intestine trypsin amount not specified 0 days 8 0.08 ug/l 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 error not defined 105418 3015
SD urine total protein excretion rate control condition Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. total urine protein amount female 96 days-121 days 7 2.2 mg/d 0.53 1.4 Bradford protein assay 0.0 0 records do not display, fixed. 110184 3166
SD serum creatinine level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood creatinine amount male 60 days 3 0.53 mg/dl 0.02 0.04 serum creatinine analysis 0.0 0 100204 2439
SD food intake rate acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 26.6 g/d unspecified method 0.0 0 84862 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 20.0 g/d unspecified method 0.0 0 84869 1602
SD plasma total protein level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 71 days-85 days 6 62.0 mg/ml 0.9 2.2 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85019 1602
SD plasma total protein level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 85 days-99 days 6 67.0 mg/ml 0.61 1.5 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85022 1602
SD blood albumin level to blood globulin level ratio acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 1.0 null 0.05 0.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 85056 1602
SD blood creatinine level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 71 days-85 days 6 1.1 mg/dl 0.15 0.36 automated blood analysis 0.0 0 Siemens biochemical analyzer 85068 1602
SD blood alanine aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 85 days-99 days 6 42.5 U/l 1.15 2.81 automated blood analysis 0.0 0 Siemens biochemical analyzer 85092 1602
SD blood alkaline phosphatase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 71 days-85 days 6 298.5 U/l 41.58 101.85 automated blood analysis 0.0 0 Siemens biochemical analyzer 85095 1602
SD heart wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 71 days-85 days 6 0.37 g 0.01 0.02 post excision weight measurement 0.0 0 85233 1602
SD heart wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 85 days-99 days 6 0.41 g 0.02 0.04 post excision weight measurement 0.0 0 85241 1602
SD spleen wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 71 days-85 days 6 0.24 g 0.01 0.03 post excision weight measurement 0.0 0 85249 1602
SD brain wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass male 71 days-85 days 6 0.77 g 0.02 0.05 post excision weight measurement 0.0 0 85254 1602
SD brain wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 71 days-85 days 6 1.11 g 0.05 0.12 post excision weight measurement 0.0 0 85262 1602
SD adrenal gland wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 85 days-99 days 6 0.04 g 0.0 0.0 post excision weight measurement 0.0 0 85276 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 205.4 g body weighing method 0.0 0 84782 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 159.1 g body weighing method 0.0 0 84817 1602
SD blood hemoglobin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 71 days-85 days 6 13.98 g/dl 0.2 0.5 unspecified method 0.0 0 84942 1602
SD blood hemoglobin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 71 days-85 days 6 11.28 g/dl 0.41 1.01 unspecified method 0.0 0 84945 1602
SD red blood cell distribution width-coefficient of variation control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 71 days-85 days 6 11.57 % 0.14 0.34 unspecified method 0.0 0 84963 1602
SD blood glucose level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 85 days-99 days 6 82.67 mg/dl 9.41 23.04 automated blood analysis 0.0 0 Siemens biochemical analyzer 84997 1602
SD blood potassium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 71 days-85 days 6 4.75 mmol/l 0.22 0.54 automated blood analysis 0.0 0 Siemens biochemical analyzer 85139 1602
SD blood total cholesterol level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 71 days-85 days 6 92.2 mg/dl 5.71 13.98 automated blood analysis 0.0 0 Siemens biochemical analyzer 85174 1602
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.3 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 720 min 98788 2160
SD heart left ventricle weight to body weight ratio sham surgical control condition (between 120 and 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.3 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 5 days 98792 2160
SD heart rate sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 389.0 beats/min 9.0 22.05 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98798 2160
SD heart rate sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 365.0 beats/min 7.0 17.15 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98805 2160
SD serum creatinine level controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. blood creatinine amount female 0 days 12 0.93 mg/dl 0.02 0.07 serum creatinine analysis 0.0 unx 97 days 100638 2499
SD blood phosphate level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 71 days-85 days 6 5.6 mg/dl 0.13 0.32 automated blood analysis 0.0 0 Siemens biochemical analyzer 85161 1602
SD liver wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 71 days-85 days 6 3.7 g 0.11 0.28 post excision weight measurement 0.0 0 85203 1602
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 34 228.0 s 14.75 86.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98201 2040
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 3.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 sham ACF 2 days 98827 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 72.0 mmHg 4.0 9.8 vascular transducer tipped catheter 1.0 ACF 360 min 98830 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 56.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98838 2160
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.3 mg/g 0.1 0.24 post excision weight measurement 1.0 sham ACF 2 days 98875 2160
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 16 34.0 null 2.95 11.8 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98220 2040
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 27.9 g/d unspecified method 0.0 0 84843 1602
SD change in body weight unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 11 66.0 g 7.84 26.0 body weighing method 0.0 unx 13 days change from surgery weight 101540 2602
SD heart wet weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 7 0.88 g 0.04 0.11 post excision weight measurement 0.0 unx 28 days 101589 2602
SD urine total protein excretion rate sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 6 19.0 mg/d 2.45 6.0 urine protein analysis 0.0 sham unx 28 days 101591 2602
SD plasma potassium level unilateral nephrectomy (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 8 5.3 mmol/l 0.14 0.4 ex vivo blood analysis 0.0 unx 14 days 101625 2602
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 15.0 g/cm2 2.0 5.66 echocardiography 0.0 ACF 28 days 99392 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 3.9 % 0.2 0.45 ex vivo light microscopy with histochemistry and digital image analysis 0.0 sham ACF 2 days interstitial collagen 99403 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 3.6 % 0.2 0.45 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 2 days 99406 2278
SD red blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 8.64 x 10E6 cells/ul 0.16 0.39 unspecified method 0.0 0 84897 1602
SD blood differential white blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 71 days-85 days 6 9.48 x 1000 cells/ul 0.6 1.46 unspecified method 0.0 0 84905 1602
SD plasma epinephrine level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 175 days 10 101.0 pg/ml 11.0 34.79 enzyme linked immunosorbent assay 0.0 ACF 105 days 99290 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 75.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99320 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 8767.0 mmHg/s 391.0 874.3 vascular transducer tipped catheter 0.0 sham ACF 2 days 99323 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -8474.0 mmHg/s 123.0 275.04 vascular transducer tipped catheter 0.0 sham ACF 2 days 99333 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 43.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days 99365 2278
SD ejection fraction sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 66.0 % 3.0 6.71 echocardiography 0.0 sham ACF 2 days 99371 2278
SD blood bilirubin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 71 days-85 days 6 0.34 mg/dl 0.02 0.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85114 1602
SD blood sodium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 71 days-85 days 6 144.7 mmol/l 0.33 0.82 automated blood analysis 0.0 0 Siemens biochemical analyzer 85120 1602
SD blood sodium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount male 71 days-85 days 6 145.2 mmol/l 0.6 1.47 automated blood analysis 0.0 0 Siemens biochemical analyzer 85121 1602
SD blood sodium level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 71 days-85 days 6 146.67 mmol/l 0.49 1.21 automated blood analysis 0.0 0 Siemens biochemical analyzer 85127 1602
SD blood sodium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood sodium amount female 85 days-99 days 6 144.33 mmol/l 0.21 0.52 automated blood analysis 0.0 0 Siemens biochemical analyzer 85129 1602
SD blood phosphate level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 71 days-85 days 6 6.0 mg/dl 0.07 0.16 automated blood analysis 0.0 0 Siemens biochemical analyzer 85156 1602
SD blood phosphate level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 71 days-85 days 6 6.1 mg/dl 0.22 0.55 automated blood analysis 0.0 0 Siemens biochemical analyzer 85157 1602
SD blood total cholesterol level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 71 days-85 days 6 96.5 mg/dl 6.17 15.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85176 1602
SD both kidneys wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 71 days-85 days 6 0.88 g 0.02 0.04 post excision weight measurement 0.0 0 85209 1602
SD heart wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 71 days-85 days 6 0.37 g 0.0 0.01 post excision weight measurement 0.0 0 85232 1602
SD heart wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass female 71 days-85 days 6 0.4 g 0.01 0.03 post excision weight measurement 0.0 0 85236 1602
SD heart wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass female 71 days-85 days 6 0.42 g 0.02 0.04 post excision weight measurement 0.0 0 85239 1602
SD spleen wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 71 days-85 days 6 0.26 g 0.02 0.04 post excision weight measurement 0.0 0 85250 1602
SD spleen wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 85 days-99 days 6 0.24 g 0.0 0.01 post excision weight measurement 0.0 0 85251 1602
SD brain wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 71 days-85 days 6 1.17 g 0.02 0.05 post excision weight measurement 0.0 0 85263 1602
SD adrenal gland wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 71 days-85 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85269 1602
SD adrenal gland wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 85 days-99 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85270 1602
SD adrenal gland wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 71 days-85 days 6 0.04 g 0.0 0.0 post excision weight measurement 0.0 0 85275 1602
SD testis wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 71 days-85 days 6 1.17 g 0.05 0.13 post excision weight measurement 0.0 0 85280 1602
SD body weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 256.6 g body weighing method 0.0 0 84774 1602
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 211.6 g body weighing method 0.0 0 84776 1602
SD body weight acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 229.6 g body weighing method 0.0 0 84777 1602
SD body weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 175.3 g body weighing method 0.0 0 84803 1602
SD body weight acetaminophen (500 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 151.9 g body weighing method 0.0 0 84806 1602
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 146.1 g body weighing method 0.0 0 84820 1602
SD food intake rate acetaminophen (500 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 36.7 g/d unspecified method 0.0 0 84833 1602
SD food intake rate acetaminophen (250 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 23.0 g/d unspecified method 0.0 0 84853 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 18.4 g/d unspecified method 0.0 0 84864 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 24.9 g/d unspecified method 0.0 0 84866 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 20.4 g/d unspecified method 0.0 0 84867 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 24.6 g/d unspecified method 0.0 0 84870 1602
SD blood glucose level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 85 days-99 days 6 90.83 mg/dl 4.2 10.28 automated blood analysis 0.0 0 Siemens biochemical analyzer 84998 1602
SD plasma total protein level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 85 days-99 days 6 54.3 mg/ml 10.45 25.6 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85015 1602
SD plasma total protein level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount female 71 days-85 days 6 83.0 mg/ml 3.84 9.4 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85020 1602
SD blood urea nitrogen level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 71 days-85 days 6 14.5 mg/dl 0.72 1.76 automated blood analysis 0.0 0 Siemens biochemical analyzer 85036 1602
SD blood urea nitrogen level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 71 days-85 days 6 15.5 mg/dl 0.76 1.85 automated blood analysis 0.0 0 Siemens biochemical analyzer 85038 1602
SD blood urea nitrogen level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 85 days-99 days 6 13.56 mg/dl 2.41 5.9 automated blood analysis 0.0 0 Siemens biochemical analyzer 85039 1602
SD blood urea nitrogen level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 71 days-85 days 6 18.7 mg/dl 0.56 1.37 automated blood analysis 0.0 0 Siemens biochemical analyzer 85041 1602
SD blood albumin level to blood globulin level ratio acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 0.9 null 0.01 0.03 automated blood analysis 0.0 0 Siemens biochemical analyzer 85049 1602
SD blood albumin level to blood globulin level ratio acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 0.9 null 0.02 0.04 automated blood analysis 0.0 0 Siemens biochemical analyzer 85050 1602
SD blood albumin level to blood globulin level ratio acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 85 days-99 days 6 0.66 null 0.15 0.37 automated blood analysis 0.0 0 Siemens biochemical analyzer 85052 1602
SD blood albumin level to blood globulin level ratio acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 85 days-99 days 6 0.97 null 0.04 0.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85058 1602
SD blood aspartate aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 71 days-85 days 6 178.5 U/l 14.68 35.95 automated blood analysis 0.0 0 Siemens biochemical analyzer 85074 1602
SD blood aspartate aminotransferase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount female 71 days-85 days 6 116.83 U/l 7.25 17.76 automated blood analysis 0.0 0 Siemens biochemical analyzer 85079 1602
SD blood alanine aminotransferase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 71 days-85 days 6 57.33 U/l 1.33 3.27 automated blood analysis 0.0 0 Siemens biochemical analyzer 85090 1602
SD blood phosphate level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 85 days-99 days 6 5.45 mg/dl 0.26 0.63 automated blood analysis 0.0 0 Siemens biochemical analyzer 85165 1602
SD liver wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 71 days-85 days 6 3.81 g 0.09 0.21 post excision weight measurement 0.0 0 85191 1602
SD blood potassium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 85 days-99 days 6 4.6 mmol/l 0.87 2.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85135 1602
SD liver wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 71 days-85 days 6 3.64 g 0.12 0.3 post excision weight measurement 0.0 0 85200 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 225.6 g body weighing method 0.0 0 84762 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 143.7 g body weighing method 0.0 0 84815 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 50 days-64 days 6 39.5 g/d unspecified method 0.0 0 84844 1602
SD blood globulin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 71 days-85 days 6 2.9 g/dl 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85023 1602
SD blood globulin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 71 days-85 days 6 3.0 g/dl 0.05 0.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 85024 1602
SD blood globulin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 71 days-85 days 6 2.9 g/dl 0.04 0.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85031 1602
SD blood globulin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount female 71 days-85 days 6 3.8 g/dl 0.21 0.51 automated blood analysis 0.0 0 Siemens biochemical analyzer 85032 1602
SD blood creatinine level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount female 71 days-85 days 6 0.3 mg/dl 0.02 0.05 automated blood analysis 0.0 0 Siemens biochemical analyzer 85067 1602
SD blood alkaline phosphatase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 85 days-99 days 6 178.67 U/l 18.2 44.59 automated blood analysis 0.0 0 Siemens biochemical analyzer 85105 1602
SD blood alkaline phosphatase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 85 days-99 days 6 228.17 U/l 50.27 123.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85106 1602
SD blood bilirubin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 85 days-99 days 6 0.6 mg/dl 0.04 0.1 automated blood analysis 0.0 0 Siemens biochemical analyzer 85117 1602
SD blood differential white blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 71 days-85 days 6 6.1 x 1000 cells/ul 0.56 1.38 unspecified method 0.0 0 84901 1602
SD blood differential white blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 85 days-99 days 6 8.68 x 1000 cells/ul 1.91 4.68 unspecified method 0.0 0 84907 1602
SD red blood cell count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 71 days-85 days 6 8.61 x 10E6 cells/ul 0.22 0.54 unspecified method 0.0 0 84909 1602
SD hematocrit acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 71 days-85 days 6 44.05 % 0.46 1.13 unspecified method 0.0 0 84953 1602
SD hematocrit control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 85 days-99 days 6 45.68 % 0.45 1.11 unspecified method 0.0 0 84955 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 21.9 g/d unspecified method 0.0 0 84849 1602
SD food intake rate acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 24.6 g/d unspecified method 0.0 0 84859 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 50 days-64 days 6 18.5 g/d unspecified method 0.0 0 84868 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 70 days-84 days 6 21.8 g/d unspecified method 0.0 0 84871 1602
SD both kidneys wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 85 days-99 days 6 0.88 g 0.04 0.11 post excision weight measurement 0.0 0 85217 1602
SD both lungs wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 71 days-85 days 6 0.77 g 0.04 0.11 post excision weight measurement 0.0 0 85221 1602
SD both lungs wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 71 days-85 days 6 0.81 g 0.05 0.13 post excision weight measurement 0.0 0 85224 1602
SD heart wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 71 days-85 days 6 0.39 g 0.01 0.03 post excision weight measurement 0.0 0 85230 1602
SD body weight acetaminophen (500 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 157.7 g body weighing method 0.0 0 84807 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 151.6 g body weighing method 0.0 0 84816 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 71 days-85 days 6 12.35 % 0.24 0.59 unspecified method 0.0 0 84964 1602
SD red blood cell distribution width-coefficient of variation control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait male 85 days-99 days 6 11.9 % 0.18 0.45 unspecified method 0.0 0 84967 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait female 71 days-85 days 6 11.38 % 0.37 0.9 unspecified method 0.0 0 84970 1602
SD platelet count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 85 days-99 days 6 1171.0 x 1000 cells/ul 54.19 132.73 unspecified method 0.0 0 84979 1602
SD platelet count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 71 days-85 days 6 919.0 x 1000 cells/ul 33.89 83.02 unspecified method 0.0 0 84983 1602
SD platelet count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 71 days-85 days 6 1025.83 x 1000 cells/ul 20.16 49.39 unspecified method 0.0 0 84984 1602
SD blood glucose level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 71 days-85 days 6 109.2 mg/dl 11.08 27.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 84994 1602
SD blood total cholesterol level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 71 days-85 days 6 92.8 mg/dl 6.06 14.84 automated blood analysis 0.0 0 Siemens biochemical analyzer 85168 1602
SD blood total cholesterol level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 85 days-99 days 6 112.17 mg/dl 3.51 8.59 automated blood analysis 0.0 0 Siemens biochemical analyzer 85177 1602
SD blood glucose level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 71 days-85 days 6 70.7 mg/dl 4.78 11.71 automated blood analysis 0.0 0 Siemens biochemical analyzer 84993 1602
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.6 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98789 2160
SD heart rate artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 419.0 beats/min 21.0 51.44 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98795 2160
SD heart rate artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 405.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98797 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 85.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 360 min 98806 2160
SD mean arterial blood pressure sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 86.0 mmHg 4.0 9.8 vascular transducer tipped catheter 1.0 sham ACF 2 days 98815 2160
SD creatinine clearance left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. glomerular filtration trait male 0 days 7 0.7 ml/min 0.26 0.69 automated serum creatinine analysis 0.0 unx 70 days 98995 2179
SD percentage of study population developing anorectal malformation during a period of time in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. anorectal integrity trait male 1 days 43 39.5 % ex vivo light microscopy with histochemistry 1.0 0 anorectal malformation incidence 98733 2158
SD body weight in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. body mass male 1 days 0 6.34 g 0.34 body weighing method 1.0 0 98736 2158
SD anogenital distance to cube root of body weight ratio in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. perineum length male 1 days 43 1.48 null 0.02 0.15 body measuring method 1.0 0 mm/g^1/3 98737 2158
SD body weight controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 13 283.6 g 3.8 13.7 body weighing method 0.0 unx 97 days 100632 2499
SD creatinine clearance controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. glomerular filtration trait female 0 days 12 0.58 ml/min 0.05 0.17 serum creatinine analysis 0.0 unx 97 days 100645 2499
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 38 181.0 s 9.08 56.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98200 2040
SD left ventricular end-systolic blood pressure sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 58.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 360 min 98831 2160
SD left ventricular end-systolic blood pressure sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 62.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 sham ACF 720 min 98833 2160
SD left ventricular end-systolic blood pressure sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 64.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 2 days 98839 2160
SD ejection fraction sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 65.0 % 2.0 4.9 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98879 2160
SD ejection fraction artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98882 2160
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 15.6 null 3.61 10.2 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 2 days 98216 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 14 22.8 null 2.97 11.1 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98217 2040
SD serum creatinine level left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. blood creatinine amount male 0 days 7 2.5 mg/dl 0.5 1.32 automated serum creatinine analysis 0.0 unx 70 days 98992 2179
SD mean arterial blood pressure control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. arterial blood pressure trait male 90 days 9 118.0 mmHg 5.0 15.0 vascular fluid filled catheter 0.0 0 101222 2582
SD glomerular filtration rate to body weight ratio control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. glomerular filtration trait male 420 days-450 days 9 0.28 ml/min/100g 0.02 0.06 inulin analysis by liquid phase colorimetry 0.0 0 101227 2582
SD urine protein excretion rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. total urine protein amount male 420 days-450 days 9 51.0 mg/d 13.0 39.0 urine protein analysis 0.0 0 101235 2582
SD systolic blood pressure unilateral nephrectomy (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 8 undefined 201.0 mmHg 6.72 19.0 tail cuff plethysmography 0.0 unx 14 days 101615 2602
SD systolic blood pressure unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 8 undefined 208.0 mmHg 6.01 17.0 tail cuff plethysmography 0.0 unx 28 days 101617 2602
SD systolic blood pressure unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 8 undefined 190.0 mmHg 9.9 28.0 tail cuff plethysmography 0.0 unx 28 days 101618 2602
SD heart wet weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 8 1.33 g 0.05 0.13 post excision weight measurement 0.0 unx 28 days 101619 2602
SD heart wet weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 8 1.21 g 0.04 0.1 post excision weight measurement 0.0 unx 28 days 101620 2602
SD urine total protein excretion rate unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 8 243.0 mg/d 26.16 74.0 urine protein analysis 0.0 unx 28 days 101624 2602
SD plasma potassium level unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 7 6.2 mmol/l 0.15 0.4 ex vivo blood analysis 0.0 unx 28 days 101597 2602
SD adrenal gland weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 7 57.0 mg 1.51 4.0 post excision weight measurement 0.0 unx 28 days 101601 2602
SD body weight sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 336.0 g 6.53 16.0 body weighing method 0.0 sham unx 13 days 101535 2602
SD body weight sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 347.0 g 7.35 18.0 body weighing method 0.0 sham unx 28 days 101571 2602
SD body weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 7 307.0 g 36.66 25.0 body weighing method 0.0 unx 28 days 101573 2602
SD change in body weight sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 99.0 g 6.53 16.0 body weighing method 0.0 sham unx 28 days change from surgery weight 101575 2602
SD change in body weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 106.0 g 10.61 26.0 body weighing method 0.0 unx 28 days change from surgery weight 101578 2602
SD heart wet weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 7 1.33 g 0.07 0.19 post excision weight measurement 0.0 unx 28 days 101588 2602
SD heart wet weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. heart mass male 0 days 6 1.28 g 0.05 0.12 post excision weight measurement 0.0 unx 28 days 101590 2602
SD urine protein level to urine creatinine level ratio left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 0.06 null 0.01 0.03 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 protein/creatinine 98962 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 7.2 null 0.7 1.85 urine protein sulfosalicylic acid precipitation test 0.0 unx 56 days 98970 2179
SD left kidney wet weight streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 1.94 g 0.02 0.07 post excision weight measurement 0.0 stz 154 days 99893 2358
SD blood glucose level streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 343.0 mg/dl 18.38 52.0 blood glucose analysis 0.0 stz 154 days 99897 2358
SD blood glucose level control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 106.0 mg/dl 4.6 13.0 blood glucose analysis 0.0 0 99898 2358
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 16 21.5 s 3.55 14.2 Morris water maze method 60.0 coronal plane rotational acceleration of the head 2 days time to platform 98242 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 11 1168.0 cm 109.45 363.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98249 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 79.3 s 16.0 48.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days time in open arms 98260 2040
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 51.9 s 6.57 19.7 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days time in open arms 98261 2040
SD body weight artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 281.0 g 4.0 9.8 body weighing method 1.0 ACF 5 days 98775 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.3 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 360 min 98777 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.5 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 720 min 98779 2160
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 10 35.3 null 2.81 8.9 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98221 2040
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.4 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98842 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 8.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98846 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.8 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98853 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98863 2160
SD body weight left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 9 300.0 g 5.0 15.0 body weighing method 0.0 unx 28 days 98930 2179
SD body weight left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 296.0 g 11.0 29.1 body weighing method 0.0 unx 28 days 98931 2179
SD mean arterial blood pressure left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 161.0 mmHg 7.0 18.52 tail cuff plethysmography 0.0 unx 56 days 98944 2179
SD mean arterial blood pressure left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 137.0 mmHg 3.0 7.94 tail cuff plethysmography 0.0 unx 70 days 98949 2179
SD urine total protein excretion rate left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 30.0 mg/d 3.0 7.94 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98955 2179
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (140 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 14 58.7 s 10.21 38.2 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days time in open arms 98223 2040
SD heart weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 2.23 g 0.11 0.35 post excision weight measurement 0.0 ACF 105 days 99198 2278
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 175 days 10 0.5 mg/g 0.1 0.32 post excision weight measurement 0.0 sham ACF 105 days 99209 2278
SD lung weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 98 days 8 1.84 g 0.08 0.23 post excision weight measurement 0.0 ACF 28 days 99212 2278
SD lung weight sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 175 days 10 1.97 g 0.06 0.19 post excision weight measurement 0.0 sham ACF 105 days 99213 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 5.0 mmHg 1.0 3.16 vascular transducer tipped catheter 0.0 sham ACF 105 days 99225 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8031.0 mmHg/s 440.0 1244.51 vascular transducer tipped catheter 0.0 sham ACF 28 days 99227 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 7529.0 mmHg/s 445.0 1407.21 vascular transducer tipped catheter 0.0 sham ACF 105 days 99229 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 43.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99370 2278
SD ejection fraction artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 76.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days 99372 2278
SD blood glucose level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood glucose amount male 140 days 6 134.7 mg/dl 5.9 14.45 blood glucose analysis 0.0 unx 84 days 100120 2419
SD creatinine clearance controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. glomerular filtration trait male 140 days 6 5.2 ml/min 0.4 0.98 urine creatinine analysis 0.0 x 0 days 100134 2419
SD creatinine clearance nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. glomerular filtration trait male 140 days 8 2.3 ml/min 0.3 0.85 urine creatinine analysis 0.0 unx 84 days 100138 2419
SD body weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 189 days 10 568.3 g 34.1 107.83 body weighing method 0.0 lad occlusion 140 days 101077 2564
SD body weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 189 days 6 532.2 g 20.4 49.97 body weighing method 0.0 sham lad occlusion 140 days 101078 2564
SD heart weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77 days 6 2.92 g/kg 0.04 0.1 ex vivo method 0.0 sham lad occlusion 28 days 101084 2564
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189 days 10 2.78 g/kg 0.07 0.22 ex vivo method 0.0 lad occlusion 140 days 101085 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189 days 10 0.87 g 0.03 0.09 ex vivo method 0.0 lad occlusion 140 days 101093 2564
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77 days 6 0.62 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101103 2564
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189 days 6 0.51 mg/g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 140 days 101106 2564
SD left atrium weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77 days 6 0.03 g 0.0 0.0 ex vivo method 0.0 sham lad occlusion 28 days 101108 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101115 2564
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 7.0 mm 0.2 0.57 echocardiography 0.0 sham ACF 28 days 99235 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 4.3 mm 0.3 0.85 echocardiography 0.0 sham ACF 28 days 99239 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 lvedd/pw 5.9 null 0.3 0.95 echocardiography 0.0 sham ACF 105 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99245 2278
SD left ventricle end-systolic wall stress sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 72.0 g/cm2 7.0 22.14 echocardiography 0.0 sham ACF 105 days 99253 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 80.0 g/cm2 6.0 18.97 echocardiography 0.0 ACF 105 days 99254 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 38.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99256 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 34.0 % 2.0 6.32 echocardiography 0.0 ACF 105 days 99258 2278
SD heart left ventricle interstitial angiotensin II level during a period of time sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 175 days 8 1.6 pg/hr 0.2 0.57 radioimmunoassay 0.0 sham ACF 105 days heart left ventricle interstitial angiotensin II level during a period of time 99261 2278
SD heart left ventricle interstitial angiotensin II level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 175 days 10 1.9 pg/hr 0.1 0.32 radioimmunoassay 0.0 ACF 105 days heart left ventricle interstitial angiotensin II level during a period of time 99262 2278
SD plasma bradykinin level sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 98 days 8 10.0 pg/ml 1.0 2.83 radioimmunoassay 0.0 sham ACF 28 days pl bk 99279 2278
SD plasma epinephrine level sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 175 days 8 75.0 pg/ml 6.0 16.97 enzyme linked immunosorbent assay 0.0 sham ACF 105 days 99289 2278
SD heart rate sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 7 312.0 beats/min 5.0 13.23 vascular transducer tipped catheter 0.0 sham ACF 28 days 99297 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 89.0 mmHg 3.0 6.71 vascular transducer tipped catheter 0.0 ACF 2 days 99300 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 4.0 mmHg 1.0 2.65 vascular transducer tipped catheter 0.0 sham ACF 28 days 99313 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 7931.0 mmHg/s 415.0 1097.99 vascular transducer tipped catheter 0.0 sham ACF 28 days 99329 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -8797.0 mmHg/s 411.0 919.02 vascular transducer tipped catheter 0.0 ACF 2 days 99332 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 8.2 mm 0.2 0.45 echocardiography 0.0 ACF 2 days 99340 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 8.0 mm 0.1 0.22 echocardiography 0.0 ACF 2 days 99342 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 5.9 mm 0.2 0.57 echocardiography 0.0 ACF 28 days 99354 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 lvedd/pw 4.2 null 0.2 0.53 echocardiography 0.0 sham ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99359 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 41.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days ledd/pw 99363 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 48.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days ledd/pw 99364 2278
SD left ventricle end-diastolic wall stress sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 4.0 g/cm2 1.0 2.24 echocardiography 0.0 sham ACF 2 days lved-ws 99387 2278
SD left ventricle end-systolic wall stress sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 65.0 g/cm2 5.0 13.23 echocardiography 0.0 sham ACF 28 days 99399 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 62.0 g/cm2 6.0 16.97 echocardiography 0.0 ACF 28 days 99402 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 4.0 % 0.3 0.67 ex vivo light microscopy with histochemistry and digital image analysis 0.0 sham ACF 2 days 99405 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 7 2.4 % 0.1 0.26 ex vivo light microscopy with histochemistry and digital image analysis 0.0 sham ACF 28 days 99408 2278
SD renal filtration fraction control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.3 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 GFR by inulin method 99913 2358
SD left kidney wet weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 2.14 g 0.04 0.12 post excision weight measurement 0.0 stz 224 days 99918 2358
SD left kidney wet weight control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney mass male 0 days 8 1.83 g 0.04 0.11 post excision weight measurement 0.0 0 99919 2358
SD systolic blood pressure control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 126.0 mmHg 1.06 3.0 tail cuff plethysmography 0.0 0 99925 2358
SD glomerular filtration rate to body weight ratio control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.69 ml/min/100g 0.02 0.06 inulin analysis by thiourea-resorcinol assay 0.0 0 99928 2358
SD effective renal plasma flow streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.27 ml/min/100g 0.06 0.18 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days 99930 2358
SD renal filtration fraction control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.0 0.01 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 GFR by inulin method 99934 2358
SD both kidneys wet weight as percentage of body weight control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. kidney mass male 120 days 3 0.55 % 0.03 0.06 post excision weight measurement 0.0 0 100194 2439
SD plasma angiotensin I level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin I amount male 60 days 3 300.0 pg/ml 103.92 180.0 enzyme immunoassay 0.0 0 100219 2439
SD plasma angiotensin I level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin I amount male 180 days 3 180.0 pg/ml 23.09 40.0 enzyme immunoassay 0.0 0 100223 2439
SD serum testosterone level in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. blood testosterone amount male 1 days 6 0.4 ng/ml 0.05 0.13 radioimmunoassay 1.0 0 98731 2158
SD retinal uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vinblastine (1 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 327.0 % 35.0 60.62 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106121 3028
SD brain uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 13.2 % 3.2 5.54 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106152 3028
SD brain uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 0.96 % 0.05 0.08 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106155 3028
SD brain uptake index of verapamil tritiated verapamil (10 uCi) (for 0 hours) and vinblastine (1 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 42.5 % 4.8 8.31 liquid scintillation counting 0.0 carotid injection 15 sec post excision verapamil uptake index 106157 3028
SD serum interleukin-9 level vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-9 amount not specified 0 days 4 0.1 ug/l 0.01 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105415 3015
SD serum interleukin-9 level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-9 amount not specified 0 days 12 0.08 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105416 3015
SD intestine trypsin level vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. intestine trypsin amount not specified 0 days 4 0.17 ug/l 0.01 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105419 3015
SD intestine trypsin level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. intestine trypsin amount not specified 0 days 12 0.23 ug/l 0.01 0.02 enzyme linked immunosorbent assay 0.0 0 error not defined 105421 3015
SD verapamil equilibrated distribution volume in brain tritiated verapamil (10 uCi) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 0.54 ml/g 0.01 0.02 liquid scintillation counting 0.0 carotid injection 15 sec post excision 106110 3028
SD timed urine volume control condition Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. urine output female 96 days-121 days 7 17.1 ml/d 2.42 6.4 metabolic cage urine volume measurement method 0.0 0 110180 3166
SD timed urine volume doxorubicin (5 mg/kg) (between 6 and 7 days) Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. urine output female 96 days-121 days 7 9.3 ml/d 0.6 1.6 metabolic cage urine volume measurement method 0.0 0 110182 3166
SD creatinine clearance control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. glomerular filtration trait male 180 days 5 0.0 ml/min 0.0 0.0 urine creatinine analysis 0.0 0 100214 2439
SD food intake rate acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 34.8 g/d unspecified method 0.0 0 84838 1602
SD blood hemoglobin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 71 days-85 days 6 13.8 g/dl 0.16 0.38 unspecified method 0.0 0 84939 1602
SD blood glucose level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 71 days-85 days 6 127.0 mg/dl 8.82 21.6 automated blood analysis 0.0 0 Siemens biochemical analyzer 84989 1602
SD blood glucose level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount male 85 days-99 days 6 62.11 mg/dl 13.41 32.84 automated blood analysis 0.0 0 Siemens biochemical analyzer 84992 1602
SD plasma total protein level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 71 days-85 days 6 62.0 mg/ml 1.27 3.1 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85013 1602
SD blood urea nitrogen level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 85 days-99 days 6 10.97 mg/dl 2.32 5.68 automated blood analysis 0.0 0 Siemens biochemical analyzer 85040 1602
SD blood creatinine level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood creatinine amount male 85 days-99 days 6 0.3 mg/dl 0.07 0.16 automated blood analysis 0.0 0 Siemens biochemical analyzer 85064 1602
SD blood alkaline phosphatase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 71 days-85 days 6 423.17 U/l 20.15 49.35 automated blood analysis 0.0 0 Siemens biochemical analyzer 85104 1602
SD blood triglyceride level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 71 days-85 days 6 92.3 mg/dl 21.39 52.39 automated blood analysis 0.0 0 Siemens biochemical analyzer 85182 1602
SD blood triglyceride level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 85 days-99 days 6 32.67 mg/dl 2.35 5.75 automated blood analysis 0.0 0 Siemens biochemical analyzer 85189 1602
SD spleen wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 71 days-85 days 6 0.29 g 0.08 0.19 post excision weight measurement 0.0 0 85243 1602
SD brain wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. brain mass female 85 days-99 days 6 1.09 g 0.04 0.09 post excision weight measurement 0.0 0 85265 1602
SD adrenal gland wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 71 days-85 days 6 0.04 g 0.0 0.0 post excision weight measurement 0.0 0 85273 1602
SD testis wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 85 days-99 days 6 1.01 g 0.03 0.08 post excision weight measurement 0.0 0 85283 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 228.0 g body weighing method 0.0 0 84784 1602
SD blood hemoglobin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 71 days-85 days 6 12.98 g/dl 0.2 0.48 unspecified method 0.0 0 84948 1602
SD red blood cell distribution width-coefficient of variation acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait female 71 days-85 days 6 11.13 % 0.35 0.85 unspecified method 0.0 0 84972 1602
SD platelet count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 71 days-85 days 6 855.83 x 1000 cells/ul 38.39 94.03 unspecified method 0.0 0 84982 1602
SD blood phosphate level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 71 days-85 days 6 6.53 mg/dl 0.39 0.96 automated blood analysis 0.0 0 Siemens biochemical analyzer 85164 1602
SD mean arterial blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 74.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 5 days 98812 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 71.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98816 2160
SD verapamil apparent influx permeability clearance in retina tritiated verapamil (10 uCi) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 0.82 ml/min/g 0.12 0.2 liquid scintillation counting 0.0 carotid injection 15 sec post excision 106102 3028
SD left ventricle end-diastolic wall stress sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 7.0 g/cm2 1.0 3.16 echocardiography 0.0 sham ACF 105 days 99249 2278
SD blood calcium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 71 days-85 days 6 10.05 mg/dl 0.08 0.2 automated blood analysis 0.0 0 Siemens biochemical analyzer 85150 1602
SD blood total cholesterol level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount female 85 days-99 days 6 109.17 mg/dl 4.94 12.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85178 1602
SD body weight unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 11 277.0 g 8.14 27.0 body weighing method 0.0 unx 13 days 101536 2602
SD body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 7 309.0 g 18.9 50.0 body weighing method 0.0 unx 28 days 101572 2602
SD left kidney wet weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 7 1.47 g 0.07 0.18 post excision weight measurement 0.0 unx 28 days remnant kidney 101581 2602
SD systolic blood pressure unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 6 undefined 186.0 mmHg 10.61 26.0 tail cuff plethysmography 0.0 unx 28 days 101586 2602
SD food intake rate unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. eating behavior trait male 0 days 8 19.0 g/d 2.83 8.0 unspecified method 0.0 unx 28 days 101611 2602
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 4.5 null 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98869 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 4.6 null 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98871 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 4.4 null 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98873 2160
SD ejection fraction sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 63.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98881 2160
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 17 16.7 s 1.96 8.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 30 days time to platform 98266 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (500 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (615 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 15.7 s 2.67 8.0 Morris water maze method 60.0 coronal plane rotational acceleration of the head 30 days time in platform 98275 2040
SD body weight acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 157.9 g body weighing method 0.0 0 84812 1602
SD glomerular filtration rate to body weight ratio control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.67 ml/min/100g 0.02 0.06 inulin analysis by thiourea-resorcinol assay 0.0 0 99904 2358
SD body weight in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. body mass male 1 days 43 4.9 g 0.06 0.39 body weighing method 1.0 0 98735 2158
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 21 1241.0 cm 71.14 326.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98212 2040
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 16 1263.0 cm 92.75 371.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days 98214 2040
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.5 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98864 2160
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 8259.0 mmHg/s 325.0 796.08 vascular transducer tipped catheter 1.0 ACF 2 days 98886 2160
SD right atrium weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189 days 6 0.04 g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 140 days 101118 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 189 days 10 0.33 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days septum 101125 2564
SD red blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 85 days-99 days 6 8.77 x 10E6 cells/ul 0.2 0.49 unspecified method 0.0 0 84913 1602
SD left ventricle end-diastolic wall stress sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 6.0 g/cm2 1.0 2.24 echocardiography 0.0 sham ACF 2 days 99389 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 16.0 g/cm2 2.0 5.66 echocardiography 0.0 ACF 28 days 99394 2278
SD left ventricular end-diastolic blood pressure sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 6.0 mmHg 1.0 2.24 vascular transducer tipped catheter 0.0 sham ACF 2 days 99307 2278
SD left ventricular end-systolic blood pressure sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 55.0 mmHg 3.0 6.71 vascular transducer tipped catheter 0.0 sham ACF 2 days 99315 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -7474.0 mmHg/s 152.0 339.88 vascular transducer tipped catheter 0.0 sham ACF 2 days 99331 2278
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 6.9 mm 0.2 0.45 echocardiography 0.0 sham ACF 2 days 99339 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 4.6 null 0.2 0.45 echocardiography 0.0 sham ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99355 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -7197.0 mmHg/s 303.0 742.2 vascular transducer tipped catheter 1.0 sham ACF 2 days 98891 2160
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -7212.0 mmHg/s 416.0 1018.99 vascular transducer tipped catheter 1.0 sham ACF 2 days 98893 2160
SD urine protein level to urine creatinine level ratio left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 3.5 null 0.5 1.32 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98965 2179
SD urine protein level to urine creatinine level ratio left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 4.8 null 0.5 1.32 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98967 2179
SD blood glucose level streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 334.0 mg/dl 19.8 56.0 blood glucose analysis 0.0 stz 154 days 99896 2358
SD systolic blood pressure streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 152.0 mmHg 1.06 3.0 tail cuff plethysmography 0.0 stz 154 days 99899 2358
SD left kidney wet weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. kidney mass male 420 days-450 days 9 1.8 g 0.12 0.36 post excision weight measurement 0.0 0 101217 2582
SD systolic blood pressure controlled losartan content drinking water (5 mg/kg/d) (for 10 days) Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 130 days 1 mean of 3 samples - 1 per minute serial mean 116.0 mmHg tail cuff plethysmography 0.0 0 100190 2439
SD blood triglyceride level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 71 days-85 days 6 52.3 mg/dl 3.15 7.71 automated blood analysis 0.0 0 Siemens biochemical analyzer 85179 1602
SD blood triglyceride level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 71 days-85 days 6 27.7 mg/dl 2.83 6.92 automated blood analysis 0.0 0 Siemens biochemical analyzer 85186 1602
SD liver wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 71 days-85 days 6 4.31 g 0.14 0.35 post excision weight measurement 0.0 0 85192 1602
SD liver wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass female 71 days-85 days 6 4.06 g 0.16 0.39 post excision weight measurement 0.0 0 85201 1602
SD heart wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass female 85 days-99 days 6 0.44 g 0.01 0.03 post excision weight measurement 0.0 0 85240 1602
SD spleen wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 71 days-85 days 6 0.24 g 0.01 0.02 post excision weight measurement 0.0 0 85248 1602
SD adrenal gland wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass male 71 days-85 days 6 0.02 g 0.0 0.0 post excision weight measurement 0.0 0 85266 1602
SD adrenal gland wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. adrenal gland mass female 85 days-99 days 6 0.04 g 0.0 0.01 post excision weight measurement 0.0 0 85277 1602
SD testis wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 71 days-85 days 6 1.17 g 0.05 0.13 post excision weight measurement 0.0 0 85278 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 242.6 g body weighing method 0.0 0 84763 1602
SD body weight acetaminophen (250 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 227.7 g body weighing method 0.0 0 84767 1602
SD body weight acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 246.8 g body weighing method 0.0 0 84778 1602
SD body weight acetaminophen (250 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 136.3 g body weighing method 0.0 0 84799 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 164.5 g body weighing method 0.0 0 84823 1602
SD food intake rate acetaminophen (250 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 23.5 g/d unspecified method 0.0 0 84854 1602
SD food intake rate acetaminophen (500 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 64 days-78 days 6 21.6 g/d unspecified method 0.0 0 84858 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 25.2 g/d unspecified method 0.0 0 84861 1602
SD blood hemoglobin level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 71 days-85 days 6 14.02 g/dl 0.28 0.69 unspecified method 0.0 0 84940 1602
SD blood hemoglobin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount female 85 days-99 days 6 12.38 g/dl 0.36 0.88 unspecified method 0.0 0 84950 1602
SD blood urea nitrogen level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount male 71 days-85 days 6 16.0 mg/dl 0.93 2.28 automated blood analysis 0.0 0 Siemens biochemical analyzer 85035 1602
SD blood urea nitrogen level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 71 days-85 days 6 15.5 mg/dl 0.76 1.87 automated blood analysis 0.0 0 Siemens biochemical analyzer 85043 1602
SD blood urea nitrogen level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 71 days-85 days 6 38.2 mg/dl 3.37 8.26 automated blood analysis 0.0 0 Siemens biochemical analyzer 85044 1602
SD blood albumin level to blood globulin level ratio control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount male 71 days-85 days 6 0.8 null 0.02 0.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85047 1602
SD blood albumin level to blood globulin level ratio acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 1.1 null 0.03 0.08 automated blood analysis 0.0 0 Siemens biochemical analyzer 85054 1602
SD blood albumin level to blood globulin level ratio control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 85 days-99 days 6 0.93 null 0.06 0.15 automated blood analysis 0.0 0 Siemens biochemical analyzer 85057 1602
SD blood alanine aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 71 days-85 days 6 46.7 U/l 2.05 5.01 automated blood analysis 0.0 0 Siemens biochemical analyzer 85083 1602
SD blood alanine aminotransferase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 71 days-85 days 6 116.5 U/l 13.45 32.94 automated blood analysis 0.0 0 Siemens biochemical analyzer 85094 1602
SD blood alkaline phosphatase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 71 days-85 days 6 327.2 U/l 66.05 161.8 automated blood analysis 0.0 0 Siemens biochemical analyzer 85097 1602
SD blood alkaline phosphatase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 85 days-99 days 6 245.33 U/l 54.57 133.66 automated blood analysis 0.0 0 Siemens biochemical analyzer 85100 1602
SD blood bilirubin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount male 71 days-85 days 6 0.3 mg/dl 0.04 0.09 automated blood analysis 0.0 0 Siemens biochemical analyzer 85107 1602
SD blood potassium level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 71 days-85 days 6 4.6 mmol/l 0.1 0.25 automated blood analysis 0.0 0 Siemens biochemical analyzer 85138 1602
SD blood potassium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount female 71 days-85 days 6 2.27 mmol/l 0.38 0.92 automated blood analysis 0.0 0 Siemens biochemical analyzer 85140 1602
SD blood phosphate level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount female 71 days-85 days 6 5.88 mg/dl 0.16 0.4 automated blood analysis 0.0 0 Siemens biochemical analyzer 85162 1602
SD blood triglyceride level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 71 days-85 days 6 141.2 mg/dl 39.8 97.48 automated blood analysis 0.0 0 Siemens biochemical analyzer 85180 1602
SD blood triglyceride level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount male 85 days-99 days 6 65.45 mg/dl 8.04 19.69 automated blood analysis 0.0 0 Siemens biochemical analyzer 85183 1602
SD liver wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 85 days-99 days 6 3.56 g 0.05 0.12 post excision weight measurement 0.0 0 85196 1602
SD blood calcium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood calcium amount female 85 days-99 days 6 10.23 mg/dl 0.13 0.32 automated blood analysis 0.0 0 Siemens biochemical analyzer 85153 1602
SD plasma total protein level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood total protein amount male 85 days-99 days 6 46.0 mg/ml 10.74 26.3 automated plasma analysis 0.0 0 Siemens biochemical analyzer 85016 1602
SD blood globulin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 71 days-85 days 6 2.9 g/dl 0.04 0.1 automated blood analysis 0.0 0 Siemens biochemical analyzer 85025 1602
SD blood globulin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood globulin amount male 85 days-99 days 6 2.12 g/dl 0.5 1.23 automated blood analysis 0.0 0 Siemens biochemical analyzer 85028 1602
SD blood aspartate aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood aspartate transaminase amount male 85 days-99 days 6 145.57 U/l 24.67 60.42 automated blood analysis 0.0 0 Siemens biochemical analyzer 85075 1602
SD blood alkaline phosphatase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 71 days-85 days 6 469.0 U/l 85.91 210.44 automated blood analysis 0.0 0 Siemens biochemical analyzer 85096 1602
SD blood alkaline phosphatase activity level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount female 71 days-85 days 6 416.5 U/l 68.13 166.88 automated blood analysis 0.0 0 Siemens biochemical analyzer 85103 1602
SD blood bilirubin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood bilirubin amount female 85 days-99 days 6 0.63 mg/dl 0.04 0.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85118 1602
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 35.0 g/d unspecified method 0.0 0 84825 1602
SD food intake rate acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 70 days-84 days 6 32.4 g/d unspecified method 0.0 0 84831 1602
SD red blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 85 days-99 days 6 8.8 x 10E6 cells/ul 0.13 0.31 unspecified method 0.0 0 84898 1602
SD blood differential white blood cell count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 71 days-85 days 6 8.81 x 1000 cells/ul 1.05 2.56 unspecified method 0.0 0 84904 1602
SD blood differential white blood cell count control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity female 85 days-99 days 6 8.24 x 1000 cells/ul 0.77 1.88 unspecified method 0.0 0 84906 1602
SD red blood cell count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 85 days-99 days 6 8.97 x 10E6 cells/ul 0.2 0.49 unspecified method 0.0 0 84914 1602
SD uterus wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. uterus mass female 85 days-99 days 6 0.27 g 0.04 0.11 post excision weight measurement 0.0 0 85289 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 57 days-71 days 6 34.9 g/d unspecified method 0.0 0 84845 1602
SD food intake rate acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait male 64 days-78 days 6 39.4 g/d unspecified method 0.0 0 84846 1602
SD both kidneys wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass female 71 days-85 days 6 0.92 g 0.03 0.08 post excision weight measurement 0.0 0 85215 1602
SD both lungs wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 71 days-85 days 6 0.68 g 0.04 0.1 post excision weight measurement 0.0 0 85220 1602
SD both lungs wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass male 85 days-99 days 6 0.64 g 0.04 0.09 post excision weight measurement 0.0 0 85223 1602
SD both lungs wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 71 days-85 days 6 0.76 g 0.02 0.06 post excision weight measurement 0.0 0 85225 1602
SD both lungs wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. lung mass female 85 days-99 days 6 0.74 g 0.04 0.11 post excision weight measurement 0.0 0 85229 1602
SD body weight acetaminophen (500 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 229.6 g body weighing method 0.0 0 84772 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 166.7 g body weighing method 0.0 0 84813 1602
SD blood differential white blood cell count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. leukocyte quantity male 71 days-85 days 6 7.68 x 1000 cells/ul 1.1 2.69 unspecified method 0.0 0 84888 1602
SD blood hemoglobin level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 71 days-85 days 6 13.68 g/dl 0.17 0.41 unspecified method 0.0 0 84941 1602
SD blood hemoglobin level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood hemoglobin amount male 85 days-99 days 6 13.75 g/dl 0.26 0.64 unspecified method 0.0 0 84944 1602
SD red blood cell distribution width-coefficient of variation control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte size trait female 85 days-99 days 6 11.32 % 0.24 0.59 unspecified method 0.0 0 84973 1602
SD platelet count acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 71 days-85 days 6 1148.83 x 1000 cells/ul 114.06 279.4 unspecified method 0.0 0 84976 1602
SD platelet count acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity female 85 days-99 days 6 931.0 x 1000 cells/ul 34.34 84.12 unspecified method 0.0 0 84986 1602
SD blood glucose level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood glucose amount female 71 days-85 days 6 116.2 mg/dl 9.03 22.13 automated blood analysis 0.0 0 Siemens biochemical analyzer 84995 1602
SD blood albumin level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 85 days-99 days 6 3.6 g/dl 0.06 0.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85009 1602
SD blood total cholesterol level acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood cholesterol amount male 71 days-85 days 6 87.8 mg/dl 3.31 8.11 automated blood analysis 0.0 0 Siemens biochemical analyzer 85169 1602
SD heart rate artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 395.0 beats/min 5.0 12.25 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98799 2160
SD mean arterial blood pressure sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 90.0 mmHg 5.0 12.25 vascular transducer tipped catheter 1.0 sham ACF 720 min 98809 2160
SD heart rate sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 260.0 beats/min 12.0 33.94 vascular transducer tipped catheter 0.0 sham ACF 28 days 99215 2278
SD blood urea nitrogen level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood urea nitrogen amount male 140 days 8 36.5 mg/dl 4.9 13.86 blood urea nitrogen analysis 0.0 unx 84 days 100156 2419
SD blood albumin level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood albumin amount male 140 days 6 3.0 g/dl 0.2 0.49 automated blood albumin analysis 0.0 unx 84 days 100162 2419
SD duration of loss of righting reflex isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. balance trait female 0 days 16 178.0 s 13.0 52.0 visual assessment of in vivo video recording 0.0 0 time to rigthing reflex post anesthesia 98198 2040
SD plasma angiotensin II level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin II amount male 180 days 3 50.0 pg/ml 5.77 10.0 enzyme immunoassay 0.0 0 100229 2439
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 6.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 ACF 2 days 98822 2160
SD left ventricular end-systolic blood pressure sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 58.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 sham ACF 5 days 98837 2160
SD left ventricular end-systolic blood pressure sham surgical control condition (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 64.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 sham ACF 2 days 98841 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.9 null 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98870 2160
SD ejection fraction artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 65.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98878 2160
SD ejection fraction artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98884 2160
SD change in body weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 48.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101610 2602
SD food intake rate unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. eating behavior trait male 0 days 8 23.0 g/d 2.12 6.0 unspecified method 0.0 unx 28 days change from surgery weight 101612 2602
SD adrenal gland weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 8 71.0 mg 1.41 4.0 post excision weight measurement 0.0 unx 28 days 101627 2602
SD plasma potassium level unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 7 5.0 mmol/l 0.15 0.4 ex vivo blood analysis 0.0 unx 28 days 101596 2602
SD kidney sclerotic glomeruli count to total glomeruli count ratio unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 7 37.2 % 10.02 26.5 ex vivo light microscopy with histochemistry 0.0 unx 28 days 101604 2602
SD creatinine clearance left nephrectomy (for 70 days) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. glomerular filtration trait male 0 days 5 1.4 ml/min 0.2 0.45 serum creatinine analysis 0.0 unx 70 days 103797 2179
SD body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 302.0 g 6.26 14.0 body weighing method 0.0 unx 13 days 101538 2602
SD change in body weight sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 6 84.0 g 4.9 12.0 body weighing method 0.0 sham unx 13 days change from surgery weight 101539 2602
SD systolic blood pressure unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 11 undefined 185.0 mmHg 7.84 26.0 tail cuff plethysmography 0.0 unx 13 days - 101548 2602
SD plasma aldosterone level sham surgical control condition (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood aldosterone amount male 0 days 6 50.0 pg/ml 4.9 12.0 plasma aldosterone analysis 0.0 sham unx 13 days 101555 2602
SD plasma aldosterone level unilateral nephrectomy (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood aldosterone amount male 0 days 11 526.0 pg/ml 78.39 260.0 plasma aldosterone analysis 0.0 unx 13 days - 101556 2602
SD plasma aldosterone level unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood aldosterone amount male 0 days 5 181.0 pg/ml 55.45 124.0 plasma aldosterone analysis 0.0 unx 13 days 101557 2602
SD adrenal gland weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 5 56.0 mg 1.79 4.0 post excision weight measurement 0.0 unx 13 days 101561 2602
SD adrenal gland weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. adrenal gland mass male 0 days 5 60.0 mg 3.13 7.0 post excision weight measurement 0.0 unx 13 days 101562 2602
SD plasma renin activity level unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. renin activity male 0 days 5 13.3 ng/ml/h 5.5 12.3 radioimmunoassay 0.0 unx 13 days 101565 2602
SD plasma renin activity level unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. renin activity male 0 days 5 5.2 ng/ml/h 2.24 5.0 radioimmunoassay 0.0 unx 13 days 101566 2602
SD left kidney wet weight sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 6 1.19 g 0.03 0.08 post excision weight measurement 0.0 sham unx 28 days remnant kidney 101579 2602
SD left kidney wet weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 6 2.03 g 0.2 0.48 post excision weight measurement 0.0 unx 28 days remnant kidney 101582 2602
SD urine total protein excretion rate unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 7 30.0 mg/d 5.67 15.0 urine protein analysis 0.0 unx 28 days 101593 2602
SD plasma potassium level sham surgical control condition (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. blood potassium amount male 0 days 6 5.0 mmol/l 0.24 0.6 ex vivo blood analysis 0.0 sham unx 28 days 101595 2602
SD glomerular filtration rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. glomerular filtration trait male 90 days 9 1.2 ml/min 0.06 0.18 inulin analysis by liquid phase colorimetry 0.0 0 101224 2582
SD glomerular filtration rate to body weight ratio control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. glomerular filtration trait male 90 days 9 0.3 ml/min/100g 0.01 0.03 inulin analysis by liquid phase colorimetry 0.0 0 101226 2582
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 17 915.0 cm 80.28 331.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98248 2040
SD number of entries into a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 9 24.5 null 5.0 15.0 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 30 days 98255 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 17 41.7 s 3.18 13.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 29 days time to platform 98265 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (210 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (250 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 17 13.6 s 1.92 7.9 Morris water maze method 60.0 coronal plane rotational acceleration of the head 31 days time to platform 98267 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 20.6 s 3.7 11.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 30 days time to platform 98272 2040
SD body weight artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 291.0 g 6.0 14.7 body weighing method 1.0 ACF 2 days 98773 2160
SD heart weight to body weight ratio sham surgical control condition (between 120 and 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.4 g/kg 0.1 0.24 post excision weight measurement 1.0 sham ACF 5 days 98784 2160
SD systolic blood pressure streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. arterial blood pressure trait male 0 days 8 undefined 128.0 mmHg 1.06 3.0 tail cuff plethysmography 0.0 stz 154 days 99900 2358
SD body weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. body mass male 90 days 9 396.0 g 7.6 22.8 body weighing method 0.0 0 101214 2582
SD hematocrit control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. erythrocyte quantity male 420 days-450 days 9 45.0 % 1.0 3.0 hematocrit analysis 0.0 0 101221 2582
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98856 2160
SD body weight left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 386.0 g 7.0 18.52 body weighing method 0.0 unx 56 days 98934 2179
SD body weight left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 346.0 g 17.0 44.98 body weighing method 0.0 unx 70 days 98937 2179
SD mean arterial blood pressure left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 115.0 mmHg 2.0 5.29 tail cuff plethysmography 0.0 unx 0 98938 2179
SD mean arterial blood pressure left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 143.0 mmHg 7.0 18.52 tail cuff plethysmography 0.0 unx 28 days 98941 2179
SD mean arterial blood pressure left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 7 155.0 mmHg 3.0 7.94 tail cuff plethysmography 0.0 unx 56 days 98946 2179
SD urine total protein excretion rate left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 0.3 mg/d 0.1 0.26 urine protein sulfosalicylic acid precipitation test 0.0 unx 0 98950 2179
SD urine total protein excretion rate left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. total urine protein amount male 0 days 7 29.3 mg/d 3.0 7.94 urine protein sulfosalicylic acid precipitation test 0.0 unx 28 days 98953 2179
SD systolic blood pressure nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. arterial blood pressure trait male 140 days 6 serial mean 142.6 mmHg 7.1 17.39 tail cuff plethysmography 0.0 unx 84 days 100118 2419
SD creatinine clearance nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. glomerular filtration trait male 140 days 6 2.6 ml/min 0.2 0.49 urine creatinine analysis 0.0 unx 84 days 100136 2419
SD systolic blood pressure controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. arterial blood pressure trait male 140 days 6 serial mean 113.6 mmHg 4.1 10.04 tail cuff plethysmography 0.0 0 100112 2419
SD blood hemoglobin A1c level controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood hemoglobin amount male 140 days 6 3.2 % 0.1 0.24 blood hemoglobin analysis 0.0 x 0 days 100126 2419
SD body weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 77 days 6 403.2 g 7.4 18.13 body weighing method 0.0 lad occlusion 28 days 101075 2564
SD heart weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77 days 6 1.13 g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 28 days 101080 2564
SD heart weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189 days 6 1.41 g 0.06 0.15 ex vivo method 0.0 sham lad occlusion 140 days 101082 2564
SD heart weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189 days 6 2.66 g/kg 0.04 0.1 ex vivo method 0.0 sham lad occlusion 140 days 101086 2564
SD systolic blood pressure sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 77 days 6 undefined 134.0 mmHg 2.0 4.9 tail cuff plethysmography 0.0 sham lad occlusion 28 days 101088 2564
SD systolic blood pressure left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 189 days 10 undefined 143.0 mmHg 3.0 9.49 tail cuff plethysmography 0.0 lad occlusion 140 days 101089 2564
SD heart left ventricle weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189 days 6 0.76 g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 140 days 101094 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77 days 6 0.25 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101099 2564
SD left atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101109 2564
SD heart left atrium weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189 days 6 0.08 mg/g 0.01 0.01 ex vivo method 0.0 sham lad occlusion 140 days law/bw 101114 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 77 days 6 0.24 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days septum 101123 2564
SD heart septum weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 77 days 6 0.23 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days septum 101124 2564
SD body weight sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 175 days 10 471.0 g 10.0 31.62 scale 0.0 sham ACF 105 days 99193 2278
SD heart weight sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 0.98 g 0.05 0.14 post excision weight measurement 0.0 sham ACF 28 days 99195 2278
SD heart weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 1.55 g 0.06 0.17 post excision weight measurement 0.0 ACF 28 days 99196 2278
SD heart weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 4.8 g/kg 0.3 0.95 post excision weight measurement 0.0 ACF 105 days 99202 2278
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 175 days 10 1.9 mg/g 0.1 0.32 post excision weight measurement 0.0 sham ACF 105 days 99205 2278
SD heart right ventricle weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 175 days 10 1.0 mg/g 0.1 0.32 post excision weight measurement 0.0 ACF 105 days 99210 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 175 days 10 82.0 mmHg 4.0 12.65 vascular transducer tipped catheter 0.0 ACF 105 days 99222 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 9.0 mmHg 1.0 3.16 vascular transducer tipped catheter 0.0 ACF 105 days 99226 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 38.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99367 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.1 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99236 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 175 days 10 7.4 mm 0.3 0.95 echocardiography 0.0 ACF 105 days 99242 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 77.0 g/cm2 8.0 22.63 echocardiography 0.0 ACF 28 days 99252 2278
SD heart left ventricle interstitial bradykinin level during a period of time sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 98 days 8 6.4 pg/hr 0.4 1.13 radioimmunoassay 0.0 sham ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99263 2278
SD heart left ventricle interstitial bradykinin level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 175 days 10 12.4 pg/hr 1.7 5.38 radioimmunoassay 0.0 ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99266 2278
SD heart left ventricle interstitial norepinephrine level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 98 days 9 6.8 pg/hr 0.8 2.4 enzyme linked immunosorbent assay 0.0 ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99268 2278
SD heart left ventricle interstitial norepinephrine level during a period of time sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 175 days 8 5.9 pg/hr 0.4 1.13 enzyme linked immunosorbent assay 0.0 sham ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99269 2278
SD plasma bradykinin level sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 175 days 8 17.0 pg/ml 2.0 5.66 radioimmunoassay 0.0 sham ACF 105 days 99281 2278
SD plasma norepinephrine level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 98 days 9 89.0 pg/ml 8.0 24.0 enzyme linked immunosorbent assay 0.0 ACF 28 days 99284 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 84.0 mmHg 5.0 11.18 vascular transducer tipped catheter 0.0 ACF 2 days 99302 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 11.0 mmHg 2.0 4.47 vascular transducer tipped catheter 0.0 ACF 2 days 99310 2278
SD left ventricular end-systolic blood pressure sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 86.0 mmHg 5.0 13.23 vascular transducer tipped catheter 0.0 sham ACF 28 days 99321 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 9386.0 mmHg/s 260.0 581.38 vascular transducer tipped catheter 0.0 ACF 2 days 99324 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -7879.0 mmHg/s 530.0 1185.12 vascular transducer tipped catheter 0.0 ACF 2 days 99334 2278
SD maximum rate of negative change in left ventricular blood pressure sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 7 -7379.0 mmHg/s 445.0 1177.36 vascular transducer tipped catheter 0.0 sham ACF 28 days 99335 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.3 mm 0.5 1.12 echocardiography 0.0 ACF 2 days 99348 2278
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 120 days 1 mean of 3 samples - 1 per minute serial mean 119.0 mmHg tail cuff plethysmography 0.0 0 100189 2439
SD both kidneys wet weight as percentage of body weight control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. kidney mass male 60 days 3 0.72 % 0.03 0.06 post excision weight measurement 0.0 0 100192 2439
SD plasma urea nitrogen level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood urea nitrogen amount male 60 days 3 6.43 mmol/l 1.65 2.86 plasma urea nitrogen analysis 0.0 0 100198 2439
SD plasma angiotensin II level control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. blood angiotensin II amount male 60 days 3 170.0 pg/ml 92.38 160.0 enzyme immunoassay 0.0 0 100225 2439
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 90 days 4 mean of 3 samples - 1 per minute serial mean 133.0 mmHg 3.0 6.0 tail cuff plethysmography 0.0 0 100170 2439
SD systolic blood pressure control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. arterial blood pressure trait male 210 days 5 mean of 3 samples - 1 per minute serial mean 136.0 mmHg 1.79 4.0 tail cuff plethysmography 0.0 0 100176 2439
SD serum testosterone level in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. blood testosterone amount male 1 days 6 0.81 ng/ml 0.05 0.12 radioimmunoassay 1.0 0 98732 2158
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 16.0 g/cm2 4.0 8.94 echocardiography 0.0 ACF 2 days 99390 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 37.0 g/cm2 7.0 15.65 echocardiography 0.0 ACF 2 days 99398 2278
SD body weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 570.0 g 31.47 89.0 body weighing method 0.0 stz 224 days 99915 2358
SD blood glucose level control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. blood glucose amount male 0 days 8 98.0 mg/dl 3.18 9.0 blood glucose analysis 0.0 0 99922 2358
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.0 0.01 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days GFR by inulin method 99932 2358
SD retinal uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and quinidine (10 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 187.0 % 22.0 38.11 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106115 3028
SD retinal uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. retina blood vessel morphology trait male 35 days-49 days 3 24.0 % 5.8 10.05 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106117 3028
SD aqueous humor uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 14.2 % 3.5 6.06 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106134 3028
SD aqueous humor uptake index of digoxin tritiated digoxin (10 uCi) (for 0 hours) and digoxin (0.01 mmol/l) (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. aqueous humor morphology trait male 35 days-49 days 3 15.8 % 3.5 6.06 liquid scintillation counting 0.0 carotid injection 15 sec post excision digoxin uptake index 106136 3028
SD brain uptake index of quinidine tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. blood-brain barrier morphology trait male 35 days-49 days 3 2.12 % 0.12 0.21 liquid scintillation counting 0.0 carotid injection 15 sec post excision quinidine uptake index 106150 3028
SD elimination half-life of nifedipine in the plasma nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. xenobiotic pharmacokinetics trait both 56 days 6 35.52 min 8.29 20.31 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling 1/2 life nifidepine 105706 3020
SD plasma nifedipine level area under curve nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. blood xenobiotic amount both 56 days 6 30118.55 min x (ng/ml) 2436.55 5968.3 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling min x ng/ml 105712 3020
SD serum total immunoglobulin E level vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood immunoglobulin E amount not specified 0 days 4 0.2 ug/l 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 error not defined 105407 3015
SD volume of distribution of nifedipine in the blood nifedipine (200 ug/kg) Lu J, et al., Sci Rep. 2017 Feb 20;7:42922. doi: 10.1038/srep42922. blood xenobiotic amount both 56 days 6 341.11 ml/kg 83.37 204.21 liquid chromatography-mass spectrometry 0.0 0 2 hour tail vein blood sampling ml/kg 105714 3020
SD serum total immunoglobulin E level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood immunoglobulin E amount not specified 0 days 12 0.28 ug/l 0.01 0.05 enzyme linked immunosorbent assay 0.0 0 error not defined 105409 3015
SD serum interleukin-9 level acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. blood interleukin-9 amount not specified 0 days 12 0.21 ug/l 0.0 0.01 enzyme linked immunosorbent assay 0.0 0 error not defined 105417 3015
SD body weight control condition Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. body mass female 96 days-121 days 7 201.0 g 4.91 13.0 body weighing method 0.0 0 110176 3166
SD urine total protein excretion rate doxorubicin (5 mg/kg) (between 6 and 7 days) Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. total urine protein amount female 96 days-121 days 7 42.8 mg/d 4.72 12.5 Bradford protein assay 0.0 0 records do not display, fixed. 110186 3166
SD creatinine clearance to body weight ratio control condition Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. glomerular filtration trait female 96 days-121 days 7 0.84 ml/min/100g 0.05 0.13 creatinine analysis by Jaffe reaction with spectrophotometric readout 0.0 0 110188 3166
SD creatinine clearance to body weight ratio doxorubicin (5 mg/kg) (between 6 and 7 days) Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. glomerular filtration trait female 96 days-121 days 7 0.74 ml/min/100g 0.08 0.2 creatinine analysis by Jaffe reaction with spectrophotometric readout 0.0 0 110189 3166
SD food intake rate control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. eating behavior trait female 57 days-71 days 6 21.4 g/d unspecified method 0.0 0 84865 1602
SD blood urea nitrogen level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood urea nitrogen amount female 71 days-85 days 6 13.3 mg/dl 0.96 2.34 automated blood analysis 0.0 0 Siemens biochemical analyzer 85042 1602
SD blood albumin level to blood globulin level ratio control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood albumin amount female 71 days-85 days 6 0.9 null 0.02 0.06 automated blood analysis 0.0 0 Siemens biochemical analyzer 85053 1602
SD blood alanine aminotransferase activity level acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount male 71 days-85 days 6 59.2 U/l 3.65 8.95 automated blood analysis 0.0 0 Siemens biochemical analyzer 85084 1602
SD blood alanine aminotransferase activity level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alanine transaminase amount female 71 days-85 days 6 46.83 U/l 2.69 6.59 automated blood analysis 0.0 0 Siemens biochemical analyzer 85089 1602
SD blood alkaline phosphatase activity level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood alkaline phosphatase amount male 71 days-85 days 6 295.8 U/l 32.68 80.04 automated blood analysis 0.0 0 Siemens biochemical analyzer 85098 1602
SD blood potassium level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 71 days-85 days 6 5.0 mmol/l 0.06 0.14 automated blood analysis 0.0 0 Siemens biochemical analyzer 85131 1602
SD blood phosphate level control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood phosphate amount male 85 days-99 days 6 4.87 mg/dl 0.9 2.2 automated blood analysis 0.0 0 Siemens biochemical analyzer 85159 1602
SD liver wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. liver mass male 71 days-85 days 6 3.65 g 0.12 0.29 post excision weight measurement 0.0 0 85194 1602
SD both kidneys wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. kidney mass male 71 days-85 days 6 0.85 g 0.03 0.07 post excision weight measurement 0.0 0 85208 1602
SD heart wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass male 85 days-99 days 6 0.36 g 0.01 0.02 post excision weight measurement 0.0 0 85235 1602
SD heart wet weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. heart mass female 71 days-85 days 6 0.42 g 0.02 0.05 post excision weight measurement 0.0 0 85238 1602
SD spleen wet weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass male 85 days-99 days 6 0.17 g 0.01 0.02 post excision weight measurement 0.0 0 85246 1602
SD spleen wet weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. spleen mass female 71 days-85 days 6 0.24 g 0.01 0.03 post excision weight measurement 0.0 0 85252 1602
SD testis wet weight acetaminophen (250 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. testis mass male 71 days-85 days 6 1.19 g 0.08 0.19 post excision weight measurement 0.0 0 85279 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 257.3 g body weighing method 0.0 0 84764 1602
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 147.0 g body weighing method 0.0 0 84810 1602
SD platelet count acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. platelet quantity male 71 days-85 days 6 1177.5 x 1000 cells/ul 83.55 204.66 unspecified method 0.0 0 84977 1602
SD body weight artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 302.0 g 5.0 12.25 body weighing method 1.0 ACF 360 min 98755 2160
SD blood potassium level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood potassium amount male 71 days-85 days 6 5.4 mmol/l 0.11 0.26 automated blood analysis 0.0 0 Siemens biochemical analyzer 85134 1602
SD blood triglyceride level acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. blood triglyceride amount female 85 days-99 days 6 23.83 mg/dl 1.49 3.66 automated blood analysis 0.0 0 Siemens biochemical analyzer 85190 1602
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.2 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 360 min 98785 2160
SD heart rate sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 395.0 beats/min 11.0 26.94 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98796 2160
SD heart rate artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then xylazine (10 mg/kg) and ketamine (80 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 378.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98803 2160
SD mean arterial blood pressure sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 103.0 mmHg 6.0 14.7 vascular transducer tipped catheter 1.0 sham ACF 360 min 98807 2160
SD blood urea nitrogen level nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. blood urea nitrogen amount male 140 days 6 38.2 mg/dl 9.0 22.05 blood urea nitrogen analysis 0.0 unx 84 days 100158 2419
SD effective renal plasma flow streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. kidney plasma flow trait male 0 days 8 2.31 ml/min/100g 0.06 0.16 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days 99906 2358
SD left kidney wet weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney mass male 0 days 5 1.16 g 0.11 0.25 post excision weight measurement 0.0 unx 13 days remnant kidney 101545 2602
SD urine total protein excretion rate unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. total urine protein amount male 0 days 5 87.0 mg/d 12.52 28.0 urine protein analysis 0.0 unx 13 days 101554 2602
SD change in body weight unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 7 97.0 g 7.56 20.0 body weighing method 0.0 unx 28 days change from surgery weight 101577 2602
SD systolic blood pressure unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. arterial blood pressure trait male 0 days 8 undefined 192.0 mmHg 7.07 20.0 tail cuff plethysmography 0.0 unx 14 days 101616 2602
SD kidney sclerotic glomeruli count to total glomeruli count ratio unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 8 26.0 % 3.89 11.0 ex vivo light microscopy with histochemistry 0.0 unx 28 days 101630 2602
SD kidney sclerotic glomeruli count to total glomeruli count ratio unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. kidney glomerulus integrity trait male 0 days 7 4.7 % 1.97 5.2 ex vivo light microscopy with histochemistry 0.0 unx 28 days 101605 2602
SD total horizontal distance resulting from voluntary locomotion in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 8 724.0 cm 144.96 410.0 elevated plus maze apparatus method 300.0 sham coronal plane rotational acceleration of the head 2 days - 98204 2040
SD left ventricular end-diastolic blood pressure sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 2.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 sham ACF 5 days 98825 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 4.4 null 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98867 2160
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 8 10.0 s 1.2 3.4 Morris water maze method 60.0 sham coronal plane rotational acceleration of the head 31 days time to platform 98264 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 28.0 s 3.53 10.6 Morris water maze method 60.0 coronal plane rotational acceleration of the head 29 days time to platform 98271 2040
SD time to locate a hidden target platform in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. spatial reference memory trait female 0 days 9 17.0 s 3.37 10.1 Morris water maze method 60.0 coronal plane rotational acceleration of the head 31 days time to platform 98273 2040
SD body weight sham surgical control condition (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 271.0 g 6.0 14.7 body weighing method 1.0 sham ACF 720 min 98772 2160
SD heart weight to body weight ratio sham surgical control condition (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.3 g/kg 0.1 0.24 post excision weight measurement 1.0 sham ACF 360 min 98778 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 4.2 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 5 days 98783 2160
SD glomerular filtration rate control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. glomerular filtration trait male 420 days-450 days 9 1.63 ml/min 0.12 0.36 inulin analysis by liquid phase colorimetry 0.0 0 101225 2582
SD plasma bradykinin level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 98 days 9 28.0 pg/ml 2.0 6.0 radioimmunoassay 0.0 ACF 28 days 99280 2278
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 307.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99296 2278
SD left ventricular end-systolic blood pressure sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 58.0 mmHg 2.0 4.47 vascular transducer tipped catheter 0.0 sham ACF 2 days 99317 2278
SD maximum rate of positive change in left ventricular blood pressure sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 8301.0 mmHg/s 442.0 988.34 vascular transducer tipped catheter 0.0 sham ACF 2 days 99325 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 5.4 null 0.4 0.89 echocardiography 0.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99358 2278
SD left atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101107 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189 days 10 0.08 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 140 days law/bw 101113 2564
SD right atrium weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 sham lad occlusion 28 days 101116 2564
SD amount of experiment time spent in a discrete space in an experimental apparatus isoflurane (4 %) (between 0.1 and 0.2 hours) then carprofen (5 mg/kg) (for 0 hours) then coronal plane rotational acceleration of the head (360 krad/s2) (for 0 hours) and coronal plane rotational acceleration of the head (380 rad/s2) (for 0 hours) Stemper BD, et al., Ann Biomed Eng. 2016 Nov;44(11):3252-3265. Epub 2016 May 17. locomotor behavior trait female 0 days 16 78.4 s 9.28 37.1 elevated plus maze apparatus method 300.0 coronal plane rotational acceleration of the head 2 days time in open arms 98226 2040
SD hematocrit acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity male 85 days-99 days 6 45.18 % 0.87 2.13 unspecified method 0.0 0 84956 1602
SD hematocrit acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. erythrocyte quantity female 85 days-99 days 6 41.5 % 0.64 1.57 unspecified method 0.0 0 84962 1602
SD both kidneys wet weight as percentage of body weight control condition Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. kidney mass male 180 days 5 0.6 % 0.02 0.04 post excision weight measurement 0.0 0 100196 2439
SD body weight control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 675.0 g 12.37 35.0 body weighing method 0.0 0 99892 2358